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ABSTRACT 
Salmonella enterica serovar Typhimurium (S. Typhimurium) is a Gram-
negative facultative anaerobe that induces severe inflammation resulting in 
gastroenteritis. In the case of S. Typhimurium infection, induction of an 
inflammatory response has been linked to its primary virulence mechanism, the 
type III secretion system (T3SS). The T3SS secretes protein effectors that exploit 
the host’s cell biology to facilitate bacterial entry and intracellular survival, and to 
modulate the host immune response. 
One such effector, SifA, is a bi-functional T3SS effector protein that plays 
an important role in Salmonella virulence. The N-terminal domain of SifA binds 
SifA-Kinesin-Interacting-Protein (SKIP), and via an interaction with kinesin, forms 
tubular membrane extensions called Sif filaments (Sifs) that emanate from the 
Salmonella Containing Vacuole (SCV). The C-terminal domain of SifA harbors a 
WxxxE motif that functions to mimic active host cell GTPases. Taken together, 
SifA functions in inducing endosomal tubulation in order to maintain the integrity 
of the SCV and promote bacterial dissemination. Since SifA performs multiple, 
unrelated functions, the objective of this study was to determine how each 
functional domain of SifA becomes processed.  
In the present study, we demonstrate that a linker region containing a 
caspase-3 cleavage motif separates the two functional domains of SifA. To test 
the hypothesis that processing of SifA by caspase-3 at this particular site is 
required for function and proper localization of the effector protein domains, we 
developed two tracking methods to analyze the intracellular localization of SifA. 
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We first adapted a fluorescent tag called phiLOV that allowed for T3SS mediated 
delivery of SifA and observation of its intracellular colocalization with caspase-3. 
Additionally, we created a dual-tagging strategy that permitted tracking of each of 
the SifA functional domains following caspase-3 cleavage to different subcellular 
locations. The results of this study reveal that caspase-3 cleavage of SifA is 
required for the proper localization of functional domains and bacterial 
dissemination. Considering the importance of these events in Salmonella 
pathogenesis, we conclude that caspase-3 cleavage of effector proteins is a 
more broadly applicable effector processing mechanism utilized by Salmonella to 
invade and persist during infection. 
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CHAPTER I: Introduction 
 
Salmonella enterica serovar Typhimurium (S. Typhimurium) is a Gram-
negative, facultative, intracellular anaerobe that causes severe inflammation of 
the intestinal mucosal epithelium resulting in gastroenteritis. S. Typhimurium 
causes disease through its primary virulence mechanism, the type III secretion 
system (T3SS). There are two T3SSs that are encoded by two regions of the 
bacterial chromosome called Salmonella pathogenicity island 1 and Salmonella 
pathogenicity island 2 (SPI-1 and SPI-2). These pathogenicity islands also 
encode effector proteins that are secreted from the T3SS and translocated into 
epithelial cells at the mucosal surface of the intestine. Upon contact with the 
mucosal epithelium, SPI-1 encoded effector proteins are translocated into 
epithelial cells and promote bacterial entry and inflammation. SPI-2 encoded 
effector proteins generally function to maintain the intracellular survival of S. 
Typhimurium after the organism has been macropinocytosed by epithelial cells. 
More recent studies, however, suggest that SPI-1 and SPI-2 effector proteins 
may not be as functionally compartmentalized as originally thought [1-3]. 
The architecture of the mucosal epithelium contains several barriers that 
attempt to prevent or impede infection by pathogenic bacteria. Mechanisms of 
protection are employed by all of these barriers in order to maintain the integrity 
of the epithelial cell monolayer and limit inflammation-associated damage (Figure 
1.1). S. Typhimurium can modulate the signaling pathways that govern these 
mechanisms, including targeting specific proteins or inducing pathways through 
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functional mimicry, in order to provide itself with an ecological advantage with its 
T3SS virulence mechanism. Although S. Typhimurium can, in certain instances, 
bypass the innate immune response, the adaptive inflammatory immune 
response is in most instances capable of clearing the pathogen, albeit with 
increased damage to the mucosal epithelium.  
 
Architecture of the Mucosal Epithelium: Barriers Against Infection 
 
Mucus/Mucins 
The luminal side of the intestinal epithelium is covered with a thick layer of 
mucus primarily composed of mucins, the main secretory product of goblet cells 
(Figure 1.1). Mucins are high molecular weight glycoproteins that aggregate to 
form a “gel-like” barrier to defend against endogenous or exogenous luminal 
insults. To date, at least 17 highly conserved mucins have been identified, each 
with varying specificities for different epithelial tissues [4]. Furthermore, these 
mucins have been categorized into two major groups: cell surface mucins and 
secreted mucins (Figure 1.1). Of these two categories, it is the secreted mucins 
that form the major structural component of the mucosal layer, and out of the 
known secreted mucin proteins, MUC2, MUC5AC, MUC5B, MUC6, and MUC19 
are classified as gel-forming for human mucosal surfaces [5, 6]. The predominant 
mucin comprising the mucus layer of the intestinal epithelium is MUC2, although  
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Figure 1.1: Architecture of the mucosal surface  
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Figure 1.1: Architecture of the mucosal surface. The mucosal surface of the 
intestine contains a single layer of epithelial cells. The monolayer of epithelial 
cells is fortified by a layer of mucus (yellow) produced by Goblet cells (blue cells 
with yellow granules). This thick mucus layer contains membrane bound and 
secreted mucins. The antimicrobial peptides (red) secreted by Paneth cells (blue 
cells with red granules) reside in the thick mucus layer, providing another form of 
protection against both pathogenic and commensal bacteria. Antimicrobial 
peptides include defensins, cathelicidins, and histatins. Plasma B cells (light 
green) reside in the subepithelial region and produce secretory IgA (blue and red 
antibody). Secreted IgA is found in the subepithelial region and the lumen. 
Resident microbiota (green) reside in the outer mucus layer, providing yet 
another barrier to pathogenic infection. The majority of resident microbiota 
belong to two phyla - Firmicutes and Cytophaga-Flavobacterium-Bacteroidetes. 
The seal between epithelial cells is maintained by tight junctions (orange bars). 
Tight junctions are dynamic structures composed of zonula occludens and 
junctional adhesion molecules. 
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MUC5AC has been shown to be expressed in the mucus layer of the fetal 
intestine [7]. 
The mucosal layer consists of an inner layer of mucus that is firmly 
adherent to the intestinal epithelial cells (mainly comprised of cell surface 
mucins) and a looser outer layer of mucus (mainly comprised of secreted 
mucins) [8]. For quite some time, the mucus layer of epithelial surfaces was 
thought to solely serve the purpose of providing a physical barrier, preventing 
access of pathogenic bacteria or resident microbiota to the epithelial cells.  
However, this is only the case for the inner, attached mucosal layer of the 
large intestine, which prevents bacterial entry due to their size [9]. In the small 
intestine, the mucosal layer is thinner and has been shown to have a higher 
degree of detachment than in the large intestine [10, 11]. The detachment and 
thinness of the mucosal layer in the small intestine not only facilitates the 
removal of both pathogenic bacteria and resident microbiota attached to the 
mucus, but also allows for a higher degree of bacterial penetration. 
It has also been increasingly realized that the mucins in the outer sublayer 
of the mucosal barrier also provide an energy source for both resident microbiota 
and pathogenic microoganisms capable of adhering to the mucus layer. This 
layer provides both commensal and pathogenic microorganisms with a niche in 
which to grow and colonize the intestine [12, 13] The inner layer of the mucosal 
surface is considered “sterile”, largely due to the presence of antimicrobial 
peptides secreted by Paneth Cells (Figure 1.1, discussed later), thereby limiting 
bacterial colonization to the outer mucus layer [8, 14, 15]. 
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Certain cell surface mucins in the inner mucus layer also directly play a 
role in protecting against bacterial colonization on the epithelial surface by acting 
as pathogen-binding decoys. For example, epithelial cells can release Muc1 
(called mucin shedding) in response to H. pylori infection, and Muc1 will bind the 
bacteria, preventing its adhesion to the intestinal epithelium [8]. Furthermore, it 
has been shown that approximately 5-fold more H. pylori colonize the intestinal 
epithelium of Muc1-/- mice than wild-type mice [16]. Although the thick mucus 
layer provides protection in the form of a physical barrier, it is significant to note 
that the necessity to maintain healthy intestinal microflora does provide 
pathogenic bacteria with the same energy source and corresponding growth 
advantage as well. This advantage has allowed certain pathogenic bacteria to 
develop mechanisms to circumvent the protection provided by the mucus 
sublayers and infect the underlying epithelial cells. As an example, certain 
pathogenic Escherichia coli (E. coli) secrete mucinolytic proteins, thus allowing 
them to persist and colonize within the mucus layer [17, 18]. Unlike E. coli, S. 
Typhimurium doesn’t enzymatically degrade mucus in order to colonize the 
mucosal epithelium. Rather, mucins have actually been shown to be the binding 
sites for S. Typhimurium, and in particular a 250 kDA neutral mucin has been 
implicated as a receptor for S. Typhimurium [13]. 
 
Resident Microbiota 
The mammalian intestinal microflora contains approximately 1014 resident 
bacteria, comprising approximately 1,000 species, and they reside in the outer 
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sublayer of the mucosal barrier on the luminal side of the intestinal epithelium 
(Figure 1.1). The vast majority (~90%) of the commensal bacteria in humans and 
mice belong to two phyla: Firmicutes and Cytophaga-Flavobacterium-
Bacteroidetes.  
Similar to the difference in the mucosal layer architecture, the composition 
of the resident microbiota differs between the large and small intestine. The small 
intestine exhibits an increase in Bacteroidetes and a decrease in Firmicutes, with 
an overall reduction in species diversity in comparison to the large intestine [19]. 
Additionally, the resident microbiota are present in reduced numbers, which 
could be caused by the consistent removal of the detached mucosal layer 
containing pathogenic bacteria and resident microbiota in the small intestine, 
though further studies would be required to address this question.  
Though much of the resident microbiota are of the same two phyla, there 
are differences in intestinal floral composition of individuals that arise at the 
species level [20]. Diversity of the intestinal microflora is susceptible to change 
due to environmental factors such as nutrition, and there is variation 
(increases/decreases in quantity of certain species of bacteria or 
increases/decreases in diversity of a particular genus of bacteria) in microbiota 
populations within different age groups [21, 22].  
The resident microbiota promote resistance to infection by pathogenic 
microorganisms in several ways. First, they serve as a microbial barrier by 
competing with pathogens for resources at the outer mucosal sublayer, thereby 
limiting pathogenic bacterial colonization [8]. Additionally, end products of 
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metabolic pathways of individual species of bacteria have been shown to prevent 
pathogenic infection. For example, Bifidobacteria carbohydrate metabolism 
produces high concentrations of acetate, which has been shown to prevent 
release of Shiga toxin during infection with enterohemmorhagic  (EHEC) 
infection, thereby decreasing the risk of toxin gaining access to the blood stream 
from where it can otherwise cause lethal damage to target organs such as the 
kidneys [23]. Along the same lines, it is becoming more appreciated that the 
composition of the intestinal microbiota may be just as important in defending 
against infection as the quantity of the commensal bacteria. For instance, 
selective reduction of Lactobacilli and Enterococci/group D streptococci groups of 
bacteria through the use of low concentrations of antibiotics has been shown to 
make mice more susceptible to colonization of the epithelial surface with S. 
Typhimurium without drastically affecting the overall numbers of commensal 
bacteria [20]. Further investigation is needed to determine exactly which resident 
microbiota are necessary to prevent other pathogens from colonizing the 
intestinal epithelium, especially since certain enteric pathogens have developed 
mechanisms to subvert this microbial form of protection. 
Nevertheless, an emerging concept is that inflammation of the mucosal 
epithelium plays a role in the bacterial fitness of S. Typhimurium. One of the 
more basic advantages of S. Typhimurium-induced inflammation is that the 
clinical manifestation of diarrhea facilitates the spread of bacteria. Additionally, it 
has been shown that unlike avirulent strains, wild-type S. Typhimurium is capable 
of out-competing commensal microbiota in re-colonization experiments after 
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treatment with antibiotics. Furthermore, S. Typhimuirum exploits inflammation to 
promote its own colonization. In this instance, S. Typhimurium has been shown 
to out-compete the resident microbiota in a mouse colitis model [24]. One 
explanation for this phenomenon is that inflammation provides S. Typhimurium 
with a respiratory electron acceptor that members of the resident microbiota are 
unable to utilize. In particular, reactive oxygen species generated by neutrophils 
(PMNs) during inflammation can react with endogenous thiosulfate to form 
tetrathionate, a respiratory electron acceptor [25]. The ability to respire 
tetrathionate has been mapped to the ttrRSBCA locus, which is located in SPI-2 
[26]. Under anaerobic conditions in which thiosulphate was oxidized to 
tetrathionate, S. Typhimurium displays a growth advantage in comparison to 
resident microbiota under the same conditions [25].  
Both resident microbiota and S. Typhimurium compete for resources 
available for fermentation at the mucosal layer; however, resident microbiota are 
incapable of using the fermentation end products [25]. By reducing the 
tetrathionate made available by the inflammatory response to infection, S. 
Typhimurium is capable of respiring the fermentation end products in anaerobic 
conditions, thereby providing it with an advantage over the resident microbiota 
[25]. Remarkably, the growth benefit is conferred to S. Typhimurium only in the 
presence of inflammation, and it has been suggested that a reason S. 
Typhimurium has evolutionarily maintained its inflammation-inducing virulence 
mechanisms could be to provide it with an ecological advantage at the mucosal 
surface of the intestine [25].  
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Paneth Cells 
Paneth cells are specialized epithelial cells located at the base of crypts of 
Lieberkuhn that generate and secrete antimicrobial peptides of approximately 20 
to 40 amino acids in length (Figure 1.1). There are four families of antimicrobial 
peptides: defensins, cathelicidins, histatins and lactoferrin (Figure 1.1, Table 1.1). 
Defensins are positively charged and directly interact with the negatively charged 
membrane of pathogenic microorganisms resulting in membrane destabilization 
and pore formation. Cathelicidins are also positively charged, and they function in 
binding and neutralizing lipopolysaccharides (LPS), ultimately resulting in pore 
formation. Unlike defensins and cathelicidins, histatins do not interact with the 
membranes of pathogenic bacteria. Instead, histatins are ingested by the 
bacteria, inhibit mitochondrial respiration, and kill the microorganism by 
generating reactive oxygen species [27]. Lactoferrin is a cationic protein that 
sequesters iron, an essential nutrient for pathogenic microorganisms.  
 
Table 1.1. Summary of antimicrobial peptides 
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Additionally, lactoferrin can bind LPS and destabilize bacterial membranes 
similar to defensins and cathelicidins [27, 28]. The antimicrobial activities of these 
peptides are nonspecific, as their activity provides a first line of defense against 
both Gram-positive and Gram-negative bacteria, fungi, and enveloped viruses.   
All antimicrobial peptides are produced in an inactive, prepropeptide form 
and must be processed (i.e. enzymatically) either intracellularly or extracellularly 
to become active [12]. For example, the alpha-defensin HD-5 is stored in Paneth 
cells in an inactive, pre-propeptide form and is processed by trypsin into its active 
form [29]. Antimicrobial peptide production has been shown to be upregulated in 
response to bacteria [30]. However, pathogenic microorganisms have developed 
methods to counteract the effectiveness of the antimicrobial peptides. Examples 
of these methods include covalently modifying the bacterial cell membrane to 
reduce its net negative charge, using bacterial proteases to catalytically 
inactivate the antimicrobial peptides, and using ATP-driven pumps to physically 
remove the antimicrobial peptides from the bacterial cytoplasm [31]. Certain 
pathogens have developed resistance to the antimicrobial activities of the 
peptides secreted by Paneth cells in order to promote their intracellular survival. 
 Antimicrobial peptides that provide protection against S. Typhimurium 
infection have been identified using transgenic mouse models. Alpha-defensin 
HD-5 transgenic mice were shown to consistently have a significant reduction in 
the S. Typhimurium burden in the distal intestine and spleen in comparison to 
	 22	
wild-type mice that do not express this antimicrobial peptide, indicating the 
antimicrobial activity of HD-5 conferred the transgenic mice with an enhanced 
ability to kill S. Typhimurium in the intestinal lumen [32]. Another alpha-defensin 
shown to provide increased defense against S. Typhimurium infection is HD-6, 
which binds bacterial membrane proteins, thereby inhibiting contact of S. 
Typhimurium with epithelial cells [33]. Since HD-6 doesn’t kill S. Typhimurium, 
HD-6 transgenic mice do not display the decrease in bacterial burden seen with 
HD-5 transgenic mice; however, HD-6 transgenic mice display a profound 
increase in survival rate in comparison to wild-type mice that do not express this 
antimicrobial peptide, indicating the antimicrobial activity of HD-6 must act in 
concert with another defense mechanisms at the mucosal barrier to eliminate S. 
Typhimurium [33].  
 In addition to defensins, mouse models have also identified the 
significance of cathelicidins and lactoferrin. The sole murine cathelicidin called 
cathelin-related antimicrobial peptide (CRAMP) has been shown to impair 
intracellular replication of S. Typhimurium in vivo and in vitro [34]. Additionally, S. 
Typhimurium displayed enhanced survival in macrophages derived from 
CRAMP-deficient mice [34]. CRAMP is similar in structure and antimicrobial 
properties to the only human cathelicidin called LL-37, which has been shown to 
display a broad spectrum of activity against bacteria including S. Typhimurium 
[35]. A recent study identified the in vivo effect of lactoferrin on S. Typhimurium. 
In this study, mice treated with bovine lactoferrin displayed a reduction in 
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severity, mortality, and inflammation during infection, indicating the antimicrobial 
properties of lactoferrin are significant for defense against S. Typhimurium [28].  
 
The Epithelial Barrier 
In addition to mucosal defenses described above, interactions between 
cells of the epithelial cells in the monolayer also provide a barrier against 
bacterial entry. Tight junctions are dynamic structures composed of zonula 
occludens (ZO) and junctional adhesion molecules that effectively adhere the 
cells of the epithelial monolayer to each other (Figure 1.1) [8]. The integrity of this 
seal is maintained by the interaction of tight junction components with the actin 
cytoskeleton. However, the permeability of this seal is regulated by physiological 
conditions, and it therefore can be manipulated. For example, treating epithelial 
monolayers with inflammatory cytokines, such as IL-1β, increases the 
permeability of the tight junctions [36]. The increase in tight junction permeability 
can facilitate the translocation of bacteria from the lumen to the subepithelial 
region, making them a target for pathogenic manipulation. Pathogenic 
microorganisms can accomplish the manipulation of tight junctions by usurping 
signaling pathways, such as the Rho GTPase pathway, which regulates actin 
cytoskeleton rearrangement [8].  
S. Typhimurium infection has been shown to regulate certain tight junction 
proteins, which ultimately promotes translocation of the bacteria through the 
epithelial cell monolayer [37]. Upon infection with S. Typhimurium, occludin 
becomes dephosphorylated and subsequently removed from epithelial tight 
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junctions [37]. Additionally, ZO-2 is recruited from the cytosol to membrane, 
indicating S. Typhimurium alters the intracellular distribution of this tight junction 
protein [37]. Suprisingly, ZO-1, which is normally regulated by pathogens in a 
similar manner to ZO-2, appears to be degraded during S. Typhimurium infection 
[37]. Manipulation of tight junction proteins serves to disrupt the epithelial barrier 
by increasing its permeability, thereby allowing S. Typhimurium to more 
effectively invade the basolateral side of the epithelial cell monolayer.  
In order to mount a successful infection, S. Typhimurium must disrupt 
some aspects of the protective mechanisms employed by the mucosal 
epithelium. As mentioned previously, the two T3SS and the secreted bacterial 
effector proteins promote entry, inflammation, and intracellular survival. In 
addition, in order to subvert the action of antimicrobial peptides, S. Typhimurium 
uses the two-component system PhoQ/PhoP, which regulates the expression of 
SPI-2 encoded genes as well. Specifically, PhoP/PhoQ regulators promote 
remodeling of the bacterial envelope, resulting in increased resistance to 
antimicrobial peptides that recognize LPS. Furthermore, the PhoP/PhoQ 
regulators repress transcription of genes for the T3SS, in attempt to avoid 
detection, and induce protective mechanisms against hydrogen peroxide [12]. In 
addition to rearranging the actin cytoskeleton and targeting specific tight junction 
proteins, S. Typhimurium also manipulates tight junctions via the action of SipA, 
SopE, SopE2, and SopB [8]. These effector proteins induce Rho-GTPase 
activation, and inhibition of this effector-induced Rho-GTPase activation prevents 
tight junction disruption [8].  
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 The manipulation of tight junctions has also recently been shown to 
facilitate the transmigration of PMNs across the epithelial cell monolayer [37]. 
The primary mechanism of PMN migration in S. Typhimurium infection involves 
the recruitment of neutrophils into the subepithelium and the formation of a 
chemoattractant gradient that directs the neutrophils into the lumen (Figure 1.2, 
discussed in detail later). However, recent research implicates the disruption of 
tight junctions in facilitating PMN migration even in the absence of the 
chemoattractant gradient [37]. Thus, S. Typhimurium not only modulates the 
release of neutrophil chemoattractants that induce PMN migration, but also 
directly influences the tight junctions that maintain the fidelity of the epithelial cell 
monolayer in order to promote bacterial translocation and PMN transepithelial 
migration. 
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Figure 1.2: Mechanism of PMN recruitment and PMN transmigration 
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Figure 1.2: Mechanism of PMN recruitment and PMN transmigration. S. 
Typhimurium utilizes its T3SS to secrete effector proteins into epithelial cells to 
activate inflammatory signaling pathways. In particular, the activation of Rho-
GTPases by SopE, SopE2, and SopB result in the induction of mitogen-activated 
protein kinase (MAPK) pathways. The stimulated pathways include ERK, JNK, 
and p38, resulting in the terminal activation of major inflammatory regulator NF-
κB. Activation of NF-κB results in the basolateral secretion of IL-8 producing a 
chemoattractant gradient that recruits neutrophils to the subepithelial region from 
the underlying microvasculature. Th17 cells are also present in the subepithelial 
region, and function to recruit and activate neutrophils in the subepithelium. PMN 
transmigration is facilitated by another chemattractant HXA3. HXA3 is a bioactive 
eicosanoid that is synthesized from arachidonic acid via the 12/15-lipoxygenase 
pathway in epithelial cells. It is secreted into the lumen via the action of an ATP-
binding cassette transporter called MRP2. S. Typhimurium effector protein SipA 
stimulates the recruitment of PKC-α to the apical membrane, which in addition to 
the ERM protein ezrin, modulate the localization of MRP2 to the apical 
membrane, thereby allowing secretion of HXA3 into the lumen and production of 
the chemoattractant gradient that induces PMN transmigration. 
 
 
 
 
 
	 28	
Lamina Propria  
The lamina propria is the connective tissue underlying the epithelial cell 
monolayer. It contains multiple immune effector cells including B cells, T cells, 
dendritic cells, natural killer cells, macrophages, eosinophils, and mast cells.  If 
enteric pathogens are capable of surmounting the barriers described above and 
penetrate the intestinal epithelium, a coordinated immune response utilizing 
these immune effector cells is activated. Sampling of luminal antigens occurs in 
specialized cells called M cells, which transport the antigens to a subepithelial 
region where the antigen comes in contact with dendritic cells. Dendritic cells 
bound to antigen then migrate to the mesenteric lymph node to present the 
luminal antigens to naïve T cells and B cells. These naïve lymphocytes then 
differentiate into several effector cells including CD8 cytotoxic T cells, CD4 helper 
T cells, regulatory T cells, and antibody secreting B cells.  
Although this marks the beginning of a coordinated immune response to 
pathogenic bacteria, the resting lamina propria does have protective functions 
that provide an added layer of defense prior to the full activation of the mucosal 
immune system.  
The most abundant B cell found in the lamina propria is the IgA-secreting 
B cell (Figure 1.1). Secreted IgA is also the primary secreted immunoglobulin 
found in the thick mucus layer. One of the main roles of secreted IgA is a process 
called immune exclusion, which includes prevention of pathogens from adhering 
to the mucosal surface on the luminal side of the intestinal epithelium and 
removal of antigens from the basoateral side of the intestinal epithelium. On the 
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luminal side, secreted IgA primarily interferes with microbial adhesins, whereas 
on the basolateral side secreted IgA functions in an export mechanism by binding 
antigens and shuttling them back across the epithelial monolayer into the lumen 
[38]. Secreted IgA does not activate an inflammatory immune response when it 
neutralizes pathogenic microorganisms, thereby upholding the integrity while 
preventing inflammation-induced damage of the mucosal epithelium [39].   
Secreted IgA also has a direct effect on the virulence mechanisms of 
certain pathogens. In S. Typhimurium infection, it has been shown that a 
monoclonal, polymeric IgA antibody Sal4 binds the O-antigen (O-Ag) component 
of LPS on the bacterial membrane, resulting in its destabilization [40, 41]. Recent 
evidence indicates that the bacterial membrane destabilization results in impaired 
T3SS translocon formation, decrease in effector protein delivery and decrease in 
flagellum-based motility [40]. S. Typhimurium responds to the binding of Sal4 to 
O-Ag by triggering exopolysaccharide (EPS) production and biofilm formation, 
though this response renders the bacteria noninvasive and avirulent [42]. The 
mechanism of EPS production and biofilm formation has been attributed to the 
activation of a cyclic dimeric guanosine monophosphate-dependent pathway via 
an inner membrane diguanylate cyclase YeaJ [42]. Furthermore, it has been 
suggested that the triggering of this pathway by S. Typhimurium could be a 
mechanism to restore membrane stability, as EPS production could serve to 
shed IgA antibody or increase resistance to other luminal insults [42]. 
The resting lamina propria contains a heterogeneous population of CD8 
cytotoxic T cells, CD4 helper T cells, and regulator T cells even in the absence of 
	 30	
pathogenic infection.  The number of effector T cells in the resting lamina propria 
would in any other tissue indicate an inflammatory response; however, the 
amount of T cells present in the mucosal tissue of the gut is more indicative of 
constant immune surveillance and recognition than chronic inflammation. The 
cytokines produced by these T cells maintain the mutualistic response to resident 
microbiota, stimulate production of IgA, induce secretion of antimicrobial 
peptides, and promote epithelial repair. Additionally, in the absence of pro-
inflammatory cytokines (which are usually produced by innate immune cells in 
the presence of pathogen) the dendritic cells in the resting lamina propria 
contribute to maintaining tolerance to non-pathogenic antigens by promoting the 
production of CD4 regulatory T cells. Regulatory T cells produce 
immunosuppressive cytokines that inhibit T cell proliferation and dendritic cell 
differentiation, which prevents unnecessary immune response to innocuous 
antigens [39].  
In addition to a heterogeneous population of T cells, the macrophages in 
the resting lamina propria play a key role in host defense against S. Typhimurium 
infection, as well. The macrophages of the resting lamina propria can be divided 
into two different classes: M1 (“classically activated”), and M2 (“alternatively 
activated”) polarized macrophages. M1 polarized macrophages are pro-
inflammatory and display high phagocytic and antimicrobial activity, whereas M2 
polarized macrophages are anti-inflammatory and display low phagocytic and 
antimicrobial activity. Hence, with this type of opposing macrophage regulation it 
is considered that M1 macrophages function in the clearance of infection versus 
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M2 macrophages that assist in wound healing and suppression of T-cell function. 
Manipulation of macrophage polarization by S. Typhimurium has become 
increasingly realized as a defense mechanism against bacterial clearance [43, 
44]. A recent study demonstrated that the SPI-1 T3SS enables S. Typhimurium 
to guide macrophage towards the M2 polarization [44]. This type of control 
permits S. Typhimurium to escape the more hostile environment of M1 polarized 
macrophages, resulting in a macrophage-specific decrease in pro-inflammatory 
signaling [44].  
The mechanism of immunity to invasive Salmonella is still disputed, 
specifically the relevance of cell-mediated versus humoral immunity. The debate 
is complicated by attempts to compare different experimental models, which vary 
in route of Salmonella administration and/or susceptibility of mouse strains to 
Salmonella. In terms of cellular immunity, mice deficient for TCR α/β, MHC class 
II or interferon- γ (IFN-γ) receptor fail to clear a primary Salmonella infection that 
can be resolved in normal mice [45, 46]. Recently, it has also been shown that 
Thy1+ natural killer (NK) cells are essential for the early production of IFN-γ 
during control of Salmonella infection [47]. CD8+ T cells seem to also play a role 
in Salmonella clearance [48]. It has also been documented that Salmonella 
infection promotes the expansion of intestinal intraepithelial lymphocytes (iIELs) 
and the activation of particularly, CD8+ TCRγδ+ iIELs, which in turn trigger 
cytolytic activity against Salmonella-infected epithelial cells [48].  
The role of antibody-producing immune cells or B cells against Salmonella 
is still controversial [49-51]. Some reports have shown the importance of 
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antibody production and T cell activation for protection from virulent Salmonella 
[49, 50]. However, another study reported that the protective immunity provided 
by an attenuated S. Typhimurium strain required B cells independently of 
antibody production, proposing that they confer protective immunity by 
presenting antigen to T cells and acting as a source of inflammatory cytokines 
[51]. It has also been demonstrated that transfer of immune serum into B cell 
deficient mice can partially but not completely provide protective immunity [52]. 
 
The Type III Secretion System: Co-opting host pathways to promote entry 
and immune evasion 
Upon contact of S. Typhimurium with the epithelial cell monolayer, the 
SPI-1 effector proteins SopE, SopE2, and SopB initiate the process of bacterial 
entry by activating host cell Rho GTPases resulting in actin rearrangements [53, 
54]. SipA is another SPI-1 effector protein that antagonizes actin depolymerizing 
agents and tethers actin monomers together to form membrane ruffles, which 
promotes bacterial internalization [55]. S. Typhimurium is engulfed by epithelial 
cells through a macropinocytosis event termed bacterial mediated endocytosis, 
and is ultimately contained within in a membrane-bound vesicle called a 
macropinosome (more commonly termed the Salmonella Containing Vacuole 
[SCV]). Although prior studies thought that SopB was the sole mediator of 
macropinosome formation, a cooperative interaction regulated by the 
phosphatase activity of SopB has implicated SopD as another mediator of this 
process [53].  
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Salmonella Typhimurium also targets antigen-sampling microfold (M) cells 
to translocate across the gut epithelium. M cells constitute a small subset of 
highly specialized follicle-associated epithelium (FAE) enterocytes overlying 
lymphoid follicles in the gut, and are characterized by an irregular brush border, a 
reduced glycocalyx and lysosomal apparatus, and are programmed to efficiently 
transcytose a wide variety of macromolecules and micro-organisms from the gut 
lumen to the underlying immune inductive Peyer’s patches (PPs) [56]. Recent 
evidence shows the S. Typhimurium type III effector protein SopB also induces 
an epithelial-mesenchymal transition (EMT) of the FAE into M cells. This cellular 
transdifferentiation is a result of SopB-dependent activation of Wnt/β-catenin 
signaling leading to induction of both receptor activator of NF-κB ligand (RANKL) 
and its receptor RANK. The autocrine activation of RelB-expressing FAE 
enterocytes by RANKL/RANK induces the EMT-regulating transcription factor 
Slug that marks epithelial transdifferentiation into M cells. Thus, S. Typhimurium 
may also transform primed epithelial cells into M cells to promote host 
colonization and invasion [56, 57].  
Following bacterial entry of mucosal epithelia, S. Typhimurium employs a 
second set of SPI-1 effector proteins to ensure repair of the actin cytoskeleton. 
SptP is one such effector that is directly responsible for reversing the affects of 
SopE and SopE2. SptP promotes restoration of the epithelial cell membrane by 
functioning as a GTPase-activating protein for the Rho GTPase proteins Rac-1 
and Cdc42 [58]. Similarly, as several of the early SPI-1 effectors induce 
inflammation of the mucosal epithelium, there are effector proteins that have an 
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anti-inflammatory function, providing S. Typhimurium with a form of regulatory 
control over the inflammatory state of the mucosal tissue (inflammation induced 
by S. Typhimurium will be discussed later).  
After successful entry into epithelial cells and restoration of the epithelial 
cell membrane, S. Typhimurium relies primarily on the T3SS encoded by SPI-2 
to survive and replicate intracellularly by translocating SPI-2 effector proteins 
across the membrane of the SCV into the epithelial cell cytoplasm. SPI-2 effector 
proteins that appear to be necessary for survival and virulence of S. Typhimurium 
inside the SCV are SifA, SseJ, SseF, SseG, SopD2, and PipB2 [54, 59, 60]. SifA 
has been shown to promote tubulation of the SCV through correlation with 
another effector protein SseJ [61].  SCV tubulation in conjunction with the effects 
of SseF and SseG localize the SCV to the perinuclear region in close proximity of 
the Golgi apparatus [62]. The localization of the SCV is important for intracellular 
survival because vesicular trafficking through the Golgi network allows for the 
acquisition of nutrients, thereby allowing the establishment of a replication niche 
for Salmonella [62, 63]. 
An additional means by which SPI-2 promotes intracellular survival of S. 
Typhimurium is by encoding factors that mediate the evasion of immune 
responses. SPI-2 promotes protection from reactive oxygen intermediates 
produced by macrophages, specifically nitric oxide (NO) and NADPH oxidase 
[64-66].  S. Typhimurium has been shown to evade NO-mediated killing in 
macrophages by inhibiting IFN-γ-induced NO production in a SPI-2 dependent 
manner [65]. SPI-2 is also involved in avoiding NADPH oxidase-dependent killing 
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by interfering with the trafficking of NADPH oxidase [66]. Although the specific 
SPI-2 effector proteins involved in the evasion of both NO-dependent and 
NADPH oxidase-dependent killing of S. Typhimurium have yet to be identified, 
the established role of SPI-2 in evasion of both immune responses suggests a 
possible role for one or more encoded effector proteins in promoting resistance 
to reactive oxygen intermediates in macrophages. 
 
Salmonella-Induced Inflammation 
Immune Recognition 
Pathogen-associated molecular patterns (PAMPs) are recognized by 
pattern-recognition receptors (PRRs), namely Toll-like receptors (TLRs), located 
on inflammatory cells and epithelial cells. TLRs can recognize a wide range of 
PAMPs, though some TLRs do show some specificity for particular PAMPs. For 
example, TLR4 is mostly involved in recognition of LPS and TLR5 is mostly 
involved in the recognition of bacterial flagellin. TLRs in epithelial cells are 
localized to the basolateral or apical membrane, as well as in intracellular 
vesicles. Thus, TLRs can recognize pathogens on either side of the epithelial cell 
monolayer and endocytosed extracellular pathogens. Additionally, inflammatory 
cells, such as macrophages, expressing TLRs can also recognize PAMPs. The 
importance of some TLRs, specifically TLR4 and TLR5, in S. Typhimurium 
infection have been established, as mutating them has been shown to increase 
susceptibility to infection and inflammation [39]. Intracellular recognition of 
bacteria or their products in the cytoplasm is also mediated by nucleotide-binding 
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oligomerization domain proteins NOD1 and NOD2. NOD1 recognizes peptides 
containing diaminopimelic acid, which is a component of Gram-negative bacterial 
cell walls, whereas NOD2 recognizes a muramyl dipeptide present in the 
peptidoclycan layers of both Gram-positive and Gram-negative bacteria. Similar 
to TLRs, mutations in NOD1 and NOD2 proteins increase susceptibility to 
disease and infection caused by intracellular bacteria [67, 68]. 
 
Recruitment of immune cells  
The host immune system also activates inflammatory pathways in 
response to infection with S. Typhimurium. The binding of TLRs and 
NOD1/NOD2 proteins to their respective ligands activates the NF-kB pathway 
leading to production of pro-inflammatory cytokines and chemokines. Basolateral 
secretion of the cytokine IL-8 recruits neutrophils and is necessary for PMN 
migration into the subepithelium. Additional chemokines, such as CCL20, play a 
role in attracting immature dendritic cells, which upon exposure to antigen, can 
mature and present antigenic peptides to naïve B and T cells in the mesenteric 
lymph nodes [39]. S. Typhimurium can also react with TLRs on macrophages in 
the subepithelial region after being transcytosed through M cells, thereby 
activating and inducing them to also produce cytokines and chemokines. 
Cytokines produced by these activated macrophages include IL-1, IL-6, and IL-
23, all of which drive the differentiation of TH17 cells whose primary function in 
the subepithelium is recruiting and activating neutrophils (Figure 1.2) [39, 69]. 
Other cytokines produced by these activated macrophages include IL-18 and IL-
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12, both of which drive the IFN-gamma-dependent production of antigen-specific 
TH1 cells [39].  
 
Mechanism of neutrophil recruitment 
A hallmark of S. Typhimurium-induced inflammation is the recruitment of 
PMNs from the underlying microvasculature to the subepithelial region of the 
epithelial cell monolayer (Figure 1.2). The neutrophils then migrate across the 
monolayer into the lumen, resulting in the inflammatory pathology of 
Salmonellosis. New information is shedding light on the molecular mechanisms 
and signaling pathways involved in neutrophil recruitment across the intestinal 
epithelium. As discussed above, it is becoming increasingly appreciated how 
inflammation induced by S. Typhimurium increases its pathogenic bacterial 
fitness.  
In addition to promoting bacterial entry, many effector proteins encoded by 
SPI-1 also activate inflammatory signaling pathways. The activation of Rho-
GTPases by SopE, SopE2, and SopB result in the induction of mitogen-activated 
protein kinase (MAPK) pathways (Figure 1.2). In particular, the ERK, JNK, and 
p38 pathways are stimulated, resulting in the terminal activation of inflammatory 
regulators AP-1 and NF-κB (Figure 1.2) [54, 70]. Furthermore, the activation of 
NF-κB and AP-1 stimulates the secretion of the cytokine IL-8 on the serosal side 
of the epithelial cell monolayer, a requirement for the recruitment of neutrophils to 
the subepithelial region (Figure 1.2) [71]. Although IL-8 is necessary for PMN 
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migration into the lumen, it has been shown that IL-8 alone is not sufficient 
enough to drive the migration across the epithelial cell monolayer [71-73].  
The migration of neutrophils from the basolateral side to the luminal side 
of the epithelial cell monolayer is driven by another PMN chemoattractant, 
hepoxilin A3 (HXA3) (Figure 1.2) [72, 74]. HXA3 is a bioactive eicosanoid that is 
synthesized from arachidonic acid via the 12/15-lipoxygenase pathway in 
epithelial cells (Figure 1.2) [74]. After synthesis, HXA3 is secreted from the apical 
surface of epithelial cells by an ATP-binding cassette transporter called multidrug 
resistant protein 2 (MRP2) (Figure 1.2) [75]. Secretion of HXA3 into the lumen 
forms a chemoattractant gradient that causes neutrophils to migrate from the 
region underlying the epithelial cell monolayer into the lumen (Figure 1.2) [74].  
Activation of the effector protein SipA has been shown to be necessary for 
induction of HXA3 synthesis and the resulting PMN migration (Figure 1.2) [76]. 
Remarkably, the mechanism for activating SipA was recently shown to require 
processing by the host enzyme caspase-3 at a particular cleavage site, resulting 
in two distinct effector domains [77]. Furthermore, the two domains were shown 
to be functionally different. The ability to promote PMN migration is confined to 
the SipA N-terminal domain, whereas the C-terminal domain has been shown to 
be involved in actin rearrangement [76, 77]. The current understanding of the 
mechanism of SipA-dependent synthesis of HXA3 is that SipA induces the 
recruitment of ADP-ribosylation factor 6 (ARF6) to the apical membrane of the 
epithelial cells. ARF6 activates phospholipase D, which generates phosphatidic 
acid. Phosphatidic acid is then converted to diacylglycerol (DAG), which recruits 
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protein kinase C-α (PKC-α) to the apical membrane (Figure 1.2). PKC-α, in 
addition to an ERM protein ezrin, modulate the localization of MRP2 to the apical 
membrane of epithelial cells, thereby allowing the secretion of HXA3 into the 
lumen and production of the chemattractant gradient that induces neutrophil 
transmigration (Figure 1.2) [76, 78, 79]. 
 
Conclusion 
The architecture of the mucosal immune system, including mucins, 
antimicrobial peptides, resident microbiota, paracellular junctions, and effector 
cells of the lamina propia, functions to prevent pathogenic bacteria from 
disrupting the epithelial cell monolayer and causing disease. If enteric pathogens 
are able to penetrate these barriers, then it results in a host inflammatory 
response and eventually activation of an adaptive immune response, designed to 
eradicate the intruding pathogen. However, S. Typhimurium has evolved 
systems, namely the SPI-1 an SPI-2 T3SS, to manipulate the defensive 
mechanisms of the mucosal immune system in order to develop a replication 
niche in the mucosal epithelium. Additionally, the ability of S. Typhimurium to 
exploit inflammation allows it to penetrate the epithelial barriers, a condition in 
which activation of the adaptive immune response would be required for 
pathogenic clearance. Investigating how S. Typhimurium exploits host cell 
signaling pathways will allow for increased understanding in its pathogenesis, 
and consequently provide further insight into how inflammation can seemingly 
result in both increased bacterial fitness and increased pathogenic clearance.  
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Thesis Objectives 
Given the numerous barriers against Salmonella infection including host 
immune response, Salmonella relies on the functions of the SPI-1 and SPI-2 
encoded effector proteins in order to evade immune response and promote it’s 
own pathogenesis. Although the functions of several effector proteins have been 
identified, the mechanism of activation for each effector protein has been much 
less appreciated.  
The combined observations from [55], [76], and [77] demonstrated that 
SipA has different functional domains, each domain can perform its indicated 
function independently, and that caspase-3 processing (also referred to as 
caspase-3 cleavage) is required for SipA function. However, all of the 
aforementioned studies focused primarily on the function and activation of SPI-1 
effector proteins (SipA and SopA). As such, we chose to take a closer look at 
SifA, a SPI-2 effector protein identified as having a caspase-3 processing site 
[77]. Determining the mechanism of SifA activation not only will broaden our 
understanding of the effector proteins encoded by Salmonella, but will also allow 
us to determine if caspase-3 processing is a general activation paradigm used by 
effector proteins to allow Salmonella to invade and persist during infection. 
Specific aims of this thesis are outlined below: 
Aim 1: Determine if SifA function is dependent upon caspase-3 cleavage 
A. Is the caspase-3 cleavage site in SifA functionally active? 
B. Is proteolytic cleavage relevant for SifA function? 
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Aim 2: Determine the role of caspase-3 processing in the subcellular localization 
of SifA 
A. Does caspase-3 colocalize with SifA during an infection? 
B. Are the subcellular locations of each domain dependent on caspase-3 
cleavage? 
a. What are the subcellular locations of the functional domains? 
Appendix A: Define the evolutionary relationship between caspase cleavage and 
their respective hosts by tracking effector evolution as an indicator of host 
adaptation 
A. What is the identity of cleavage sites in different strains of Salmonella? 
a. Is the identity of the cleavage site related to host specificity? 
B. When do we first see the emergence of cleavage sites? 
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PREFACE TO CHAPTER II 
The data within this chapter has been accepted for publication and is 
found in the following paper: 
 
Patel, S., Wall, D.M., Castillo, A., & McCormick, B.A. Caspase-3 
cleavage of Salmonella Type III secreted effector protein SifA is 
required for localization of functional domains and bacterial 
dissemination. Accepted for publication in Gut Microbes. July 2018. 
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CHAPTER II: Caspase-3 cleavage of Salmonella Type III secreted 
effector protein SifA is required for localization of functional 
domains and bacterial dissemination 
 
Introduction 
Salmonella enterica serovar Typhimurium (S. Typhimurium) is a Gram-
negative, facultative, intracellular anaerobe that causes gastroenteritis. In the 
United States, S. Typhimurium is responsible for nearly 25% of all food-borne 
infections and continues to be a major public health and economic burden [80]. 
S. Typhimurium infection in humans is typically acquired by ingestion of 
contaminated food or water leading to acute gastroenteritis, and can also lead to 
severe complications or death in persons at risk [81]. Salmonella species, like 
other Gram-negative pathogens, have a sophisticated virulence mechanism 
called a type III secretion system (T3SS), which is responsible for the delivery of 
a series of bacterial effectors into host cells aimed at reprogramming eukaryotic 
cell functions [82-84]. S. enterica use two distinct type III T3SSs encoded 
on Salmonella pathogenicity islands (SPIs)-1 and-2 to inject their arsenal of 
effectors. In general, the SPI-1-encoded T3SS is primarily required for the 
invasion of non-phagocytic cells, where expression is induced by the intestinal 
microenvironment, enabling Salmonella to cross the epithelial gut barrier and 
promote intestinal inflammation. Subsequently, the SPI-2-encoded T3SS 
mediates intracellular bacterial replication and is necessary for the establishment 
of systemic disease.  
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The type III secreted effectors (T3SEs) constitute a large and diverse 
group of virulence proteins that mimic eukaryotic proteins in structure and 
function. In fact, over 30 different effector proteins are delivered into host cells by 
S. Typhimurium through both SPI-1 and SPI-2 T3SSs [85]. A prominent feature 
shared by bacterial effectors is their modular architecture, which is often 
comprised of well-defined regions that confer a subversive function. Strikingly, 
the distinct modules within an effector often mediate very different, unrelated 
functions, strongly suggesting that they evolved independently of each other and 
subsequently combined to form a chimeric protein [86, 87]. Chimerization is a 
common theme shared by many effectors [88], and this forms the basis of a 
provocative hypothesis termed ‘terminal reassortment’, proposed by Guttman 
and colleagues to explain the diversity of bacterial effectors [87]. The terminal 
reassorment tenet is substantiated by their finding that 32% of all T3SE families 
contain chimeric effectors, far greater than any other analyzed protein family. 
Additionally, other studies suggest that terminal reassortment is important for the 
evolution of these virulence proteins [86, 87]. In keeping with this theory, we 
previously observed that many T3SEs harbor a functional caspase-3 cleavage 
motif (DxxD) uniquely positioned at the junction separating the two distinct 
functional domains [77]. This finding revealed that T3SEs had evolved to use the 
host defense system in a manner pivotal to the pathogenicity of the organism 
[77]. More specifically, S. Typhimurium appears to have evolved a mechanism to 
deliver effector proteins in a precursor form to the host cell where they are 
processed into independent functionally active domains. 
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Although much attention has been given to identifying the functions of 
T3SEs, mechanisms underlying host mediated effector processing (e.g., 
cleavage) are far less appreciated. To further our understanding in this regard, 
we had previously examined at two SPI-1 effector proteins, SipA and SopA, and 
found that caspase-3 processing was necessary for the function of these T3SEs 
[77]. In this report, we chose to take a closer look at SPI-2, which mediates the 
translocation across the vacuolar membrane of a set of bacterial effector 
proteins that support collectively the intra-vacuolar replication. One such SPI-2 
effector protein SifA [60] plays a significant role in Salmonella virulence by 
maintaining the integrity of the Salmonella-containing vacuole (SCV) [89], and 
hence promoting the formation of tubular membranous structures connected to 
SCVs that are named Salmonella-induced tubules (also referred to as Sif 
filaments) [61]. Unique to this effector protein, the N-terminal domain of SifA 
interacts with the pleckstrin homology domain of the host kinesin-binding protein 
SKIP, and the C-terminal domain harbors a WxxxE motif that mimics the active 
the form of Rho-GTPases. Cooperatively these functional domains, along with 
another SPI-2 T3SE SseJ, promote host membrane tubulation [61].  
The resolution of the crystal structure and domain function analysis of SifA 
has shown that the protein is divided into two distinct major domains [61, 90] 
separated by a potential caspase-3 cleavage site [77, 91], suggesting the two 
domains of SifA might act independently of each other upon cleavage. Herein we 
characterize the structural features of the caspase-3 cleavage motif in SifA, and 
describe a new method of tracking T3SEs to show that cleavage of SifA by 
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caspase-3 is indeed critical for proper localization of its functional domains, and 
is essential for bacterial dissemination. Understanding how T3SEs are 
functionally controlled through caspase-3 processing, will shed new light 
concerning the co-evolutionary interplay between S. Typhimurium and its host. 
 
Materials and Methods 
Bacterial strains, plasmids, and growth conditions 
Wild type S. Typhimurium SL1344, and isogenic mutants thereof (Table 2.1), 
were used throughout this study. All cloning was carried out in Escherichia coli 
strain BL21 DE3 (Invitrogen). All bacterial strains were constructed and cultured 
in LB as previously described [92], unless otherwise specified. Primers used for 
construction of bacterial plasmids are listed in Table 2.2. 
 
Table 2.1. Bacterial Strains and Plasmid Constructs 
GST-SifA This Paper based on Ohlson 2008 
GST-SifAcsm This Paper 
∆SifA This Paper  
∆SifA/pGST-SifA and ∆SifA/pGST-SifAcsm This Paper 
∆SifA/SifA-phiLOV This Paper 
V5-SifA-HA, V5-SifA, SifA-HA, V5-SifAcsm-HA This Paper 
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Table 2.2. Primers used for construction of bacterial plasmids (5’à 3’) 
SP1 
CCGATTACTATAGGGAATGGTTTTTTAAAAAGTGAAATCCTTACCAACTCGTGTAGGCTGG
AGCTGCTTCG 
 
SP2 
AAAACAACATAAACAGCCGCTTTGTTGTTCTGAGCGAACGTGTAGCGTGGCATATGAATA
TCCTCCTTAGT 
 
SP3 
ATCCGCGGTAGTCCTTCTTT 
 
SP4 
CAGAGGATGGGGTGCTTTTA 
 
SP5 
GCGCGCGAATTCCCGATTACTATAGGGAATGGTTT 
 
SP6 GCGCGCCTCGAGTTATAAAAAACAACATAAACAGCCGC 
SP7 
GCGCGCGAGCTCATGCCGATTACTATAGGGAATGGTTT 
 
SP8 
GCGCGCCTCGAGTAAAAAACAACATAAACAGCCGC 
 
SP9 
CGATCCCGCGAAATTAATACGACTC 
 
SP10 
CAAAAAACCCCTCAAGACCCGTTTA 
 
 
-GST-SifA  
SifA was PCR-amplified from wild-type (WT) S. Typhimurium (SL1344) using 
primers SP5 and SP6. The PCR product was then digested, purified, and ligated 
to the GST-containing vector, pGEX-6p-1 (GE Healthcare), as described 
previously [61]. 
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-GST-SifAcsm  
SifAcsm was synthetically generated and cloned into pUCIDT-AMP by Integrated 
DNA Technologies (IDT) using the same cloning sites as GST-SifA.  sifAcsm was 
then cloned into pGEX-6p-1 and sequences were verified using the same 
methods used for GST-SifA. 
 
-∆SifA 
The ∆SifA mutant was constructed from SL1344 by deletion mutagenesis using a 
chloramphenicol cassette as described by Datsenko and Wanner [93]. Briefly, a 
chloramphenicol resistance cassette was PCR amplified from the pKD3 plasmid 
using primers SP1 and SP2. The pKD3 PCR product was then concentrated and 
transformed into electrocompetent SL1344 expressing the pKD46 plasmid. The 
sifA deletion was sequence verified using SP3 and SP4 primers. 
 
-∆SifA/pGST-SifA and ∆SifA/pGST-SifAcsm 
The ∆SifA/pGST-SifA and ∆SifA/pGST-SifAcsm complemented strains were 
made using the ∆SifA mutant. pGST-SifA and pGST-SifAcsm plasmid DNA were 
transformed into the electrocompetent ∆SifA strain of Salmonella. Transformants 
were sequence verified using SP3 and SP4 primers. 
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-∆SifA/SifA-phiLOV 
SifA-phiLOV was made using pUC57-SipA-phiLOV. sifA was PCR amplified from 
SL1344 using SP7 and SP8 primers. These primers added a SacI and XhoI site 
on the 5’ and 3’ ends of sifA, respectively. Since sipA was cloned into pUC57-
phiLOV using the same cloning sites, the pUC57-SipA-phiLOV plasmid was 
digested with SacI and XhoI (NEB) to remove sipA, and then gel purified [94]. 
The sifA PCR product was similarly digested and purified and ligated to pUC57-
phiLOV before being transformed in the same manner as pGST-SifA. Plasmid 
DNA was then isolated from transformants that had ampicillin resistance and 
transformed into electrocompetent ∆SifA. 
 
-Single/Dual Tagged SifA Constructs for Lentiviral Transduction 
V5-SifA-HA, V5-SifA, SifA-HA, and V5-SifAcsm-HA constructs were generated 
and cloned into pUC57 with AgeI and EcoRI cloning sites by Genscript. Both V5 
and HA are small ectopic tags that can be visualized using fluorescent 
antibodies. Plasmids were then digested with AgeI and EcoRI, and cloned into 
pLVX-TetOne-Puromycin and pLVX-TetOne-Blasticidin using the same 
restriction sites. 
 
-SifA Purification 
A 10 mL overnight culture of Escherichia coli BL21 expressing pGST-SifA in 
LB/Ampicillin media was back diluted 1:100 into a 1 L LB/Ampicillin.  The culture 
was grown at 37oC for 3.5 hr and then induced with 1 mM IPTG at 22oC for 3 hr.  
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The bacteria were resuspended in GST Lysis Buffer (25 mM Tris pH 8, 150 mM 
NaCl, 3 mM DTT, and 1 mM PMSF) and then sonicated for 30 sec intervals 4 
times. The lysate was then clarified at 14,000 rpm for 1 hr at 4 degrees Celsius. 
The clarified lysate was then run through glutathione sepharose beads in a 
column (GE Healthcare), washed with 1 X phosphate buffered solution (PBS), 
and then eluted using reduced glutathione (GE Healthcare).  
 
Caspase-3 Cleavage Assay 
Purified GST-SifA and GST-SifAcsm were incubated with 10U and 20U of active 
recombinant human caspase-3 (BioVision) for 1 hr at 37oC. The resulting 
products were then Western blotted using Anti-GST antibody (GE Healthcare). 
Densitometry analysis was performed using the free online software FIJI. 
 
Mouse Dissemination and Colonization Experiments (Both oral and tail vein 
infection) 
For intestinal colonization, mice were treated with 40 uL of 100 mg/mL 
streptomycin 24 hrs prior to infection, as described previously [76]. Mice were 
then infected with 1 x 107 colony forming units (CFUs) of each bacterial strain by 
oral gavage. At 48 hr post-infection (hpi) the liver and proximal colon were 
harvested for dissemination analysis. Dissemination analysis was completed by 
homogenizing the tissues and serial dilution plating.  For tail vein injection, mice 
were injected with 1 x 106 bacteria and dissemination analysis was again carried 
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out but at 24 hpi. Statistical analyses were completed using an unpaired 
Student’s t test. 
 
Generation of Caspase-3 KO HeLa cells  
The caspase-3 KO HeLa cells were generated according to the Caspase-3 
CRISPR/Cas9 construct manufacturer’s instructions (Santa Cruz Biotechnology). 
Briefly, 1µg of the Caspase-3 CRISPR/Cas9 plasmid and 1µg of the HDR 
plasmid (contains puromycin resistance marker for selection) were incubated 
with Plasmid Transfection Medium (Santa Cruz Biotechnology). Ten µL of the 
UltraCruz Transfection Reagent (Santa Cruz Biotechnology) was incubated with 
Plasmid Transfection Medium. The solution containing the plasmids and the 
solution containing the UltraCruz Transfection Reagent were then combined and 
incubated at room temperature for 20 min. After incubation, the combined 
solution was added to HeLa cells in fresh H1 media. H1 media was replaced 24 
hr later, and selection with H1 media containing 2 µg/mL puromycin was started 
72 hr post-transfection. Cells were sub-cultured for 2 weeks before use in 
experiments. 
 
Lentiviral transduction of WT and Caspase-3 KO HeLa cells  
Six µg of each construct was cloned into pLVX-TetOne-Puro (for WT HeLa cells) 
or pLVX-TetOne-Blasticidin (for Caspase-3 KO HeLa cells), 4µg of a packaging 
plasmid psPAX2 and 2ug of an envelope plasmid pMD2.G were added to Opti-
MEM media (Difco). Thirty-six µL of TransIT-293 transfection reagent was added 
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to the Opti-MEM mixture and incubated at room temperature for 30 min. The 
transfection mixture was then added dropwise to individual 10 cm dishes of 
HEK293T cells. HEK293T cells were plated at 6-8 x 106 in 8 mLs of D10 media 
(made using 500 mL DMEM, 10 % FBS, 5 mL Pen/Strep, 10 mL L- glutamine, 
and 50 µL plasmocin, Invivogen).  
 After 48 hr, the supernatant containing the virus from each plate was 
collected and added dropwise to WT HeLa cells (constructs in pLVX-TetOne-
Puro) or caspase-3 KO HeLa cells (constructs in pLVX-TetOne-Blasticidin) that 
were >60% confluent. Both WT and caspase-3 KO HeLa cells were incubated 
with virus overnight, and then selected using puromycin or blasticidin, 
respectively.  
 
In vitro infection experiments  
A 3 mL overnight LB culture of SL1344 or LB/Ampicillin cultures of ∆SifA/pSifA-
phiLOV were back-diluted 1:5 into 10 mL LB broth or LB/Ampicillin/1 mM IPTG, 
respectively, and grown at 37oC for 1hr. Fifty µL of this culture was then added to 
1mL H1 media, and 200 µL per well was used for infection of WT and caspase-3 
KO HeLa cells. Following a 1 hr infection, the cells were incubated with H1 media 
containing 50 µg/mL gentamicin for 1 hr, before incubation with H1 media 
containing 10 µg/mL gentamicin until 1, 2, 4, 8, and/or 10 hpi. Cells were fixed 
and permeabilized in 1 % bovine serum albumin (BSA)/0.2 % saponin then 
stained using Image-iT LIVE Caspase-3 Detection Kit (ThermoFisher) for SifA-
phiLOV/Caspase-3 colocalization experiements. For dual-tagged SifA constructs, 
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cells were stained using anti-V5 (Abcam) and anti-HA primary antibodies (Santa 
Cruz), and goat anti-rabbit Alexa Fluor 488 and goat anti-mouse Alexa Fluor 568 
secondary antibodies (Invitrogen). Cells were then visualized using a 63X 
objective lens on a confocal microscope Leica SP5 confocal microscope. 
Colocalization data was determined using the Coloc 2 tool in the free online 
software FIJI. The Mander’s coefficient was the selected output, which is a pixel 
intensity spatial correlation analysis. 
 
Results 
Structural features of the caspase-3 motif in S. Typhimurium T3SE SifA  
Given that the resolution of the crystal structure and domain function 
analysis of SifA has shown that the protein is divided into two distinct major 
domains [61, 90] separated by a potential caspase-3 cleavage site [77, 91], we 
investigated the structural features of the caspase-3 cleavage motifs by in silico 
modeling of the crystallized caspase-3 substrate [61, 91].  Protein sequences 
were retrieved from the NCBI protein database, screened for caspase-3 motifs, 
and then analyzed in the web server Phyre2 for the identification of structural 
homologues. We found that the caspase-3 motif is surrounded by hydrophilic 
residues, exposed at the surface, and localized in coiled regions of proteins 
(Figure 2.1). Additionally, we studied the frequency of the DxxD site by analyzing 
the residue downstream of the caspase-3 cutting site (DxxD-x) in 33 known 
caspase-3 substrates [95]. Of these residues, serine, glycine, and asparagine (all 
hydrophilic/polar residues) are most frequently located downstream of the 
	 54	
caspase-3 cleavage site; serine was found 13 times, glycine 10 times, and 
asparagine 4 times and is consistent with our observation of the CASP3 motif 
being surrounded by hydrophilic residues. 
 
Figure 2.1 The structural characteristics of the caspase-3 motif  
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Figure 2.1 The structural characteristics of the caspase-3 motif. The 
structural features of the caspase-3 motif found in the Salmonella effector protein 
SifA (PDB ID 3CXB). Protein structures are displayed as cartoon (Panels a and 
b), surface (Panel c), and spheres (Panel c). Panel (a) shows protein structures 
colored with the spectrum color set of PyMOL to display the different protein 
domains, α-helixes, β-sheets, and coil regions. In Panels (b) and (c), the location 
of the caspase-3 motif is colored in red, whereas in Panel (d) in yellow. In Panel 
(d), polar residues are colored in pink and hydrophobic in grey. DRPD, DVHD, 
and DGQD are putative caspase-3 motifs. PDB; Protein data bank. SifA: 
Confidence 100%; Identity 79%; Coverage 90%.  
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SifA Harbors a Functionally Active Caspase-3 Cleavage Site  
SifA is a SPI-2 S. Typhimurium effector protein necessary for intracellular 
survival. Based on the structural data as shown in Figure 2.1, as well as the 
observation that each of the SifA domains function independently [61, 91], we 
next sought to determine whether the caspase-3 motif of SifA (DRPD) is 
functionally active. To do this we PCR amplified SifA from SL1344 and cloned it 
into pGEX-6p-1 (GE Healthcare), which adds an N-terminal GST tag to SifA that 
has been previously used to purify SifA protein using a glutathione sepharose 
matrix [61]. We found that that exogenous addition of purified fractions of SifA 
(5µg) with commercially obtained active caspase-3 enzyme (10U and 20U) 
(Biovision) resulted in the cleavage of this effector protein at the expected site as 
evidenced by a decrease in the amount of SifA protein and concomitant increase 
in degradation products (Figure 2.2A, 2.2B).  Additionally, a single amino acid 
substitution in the caspase-3 recognition site is known to render substrates 
insensitive to caspase-3. Thus, we altered the caspase-3 site (DRPD) by one 
amino acid to DRPA (refer to methods). The plasmid bearing the mutant clone 
was sequence confirmed and named pSifAcsm (for SifA caspase site mutant). 
Such mutation of the caspase-3 site by one amino acid to alanine rendered SifA 
insensitive to caspase-3 cleavage (Figure 2.2A, 2.2B). 
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Figure 2.2 SifA harbors a functionally active caspase-3 cleavage site  
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Figure 2.2 SifA harbors a functionally active caspase-3 cleavage site. A.) 
Purified fractions of SifA and SifAcsm (5µg) were incubated with 10 units or 20 
units of human recombinant caspase-3 (Biovision) for 1 hr at 37 ºC. Each sample 
was then Western blotted using an Anti-GST primary antibody (GE Healthcare) 
at 1:20,000 and Donkey anti-Goat IgG HRP secondary antibody (Santa Cruz) at 
1:5,000. The cleavage products for both SifA and SifAcsm were visualized using 
coomassie blue staining (BioRad). SifA protein, but not SifAcsm protein, was 
cleaved by caspase-3 in a concentration dependent manner. B.) Densitometry of 
Western Blot in (A), SifA (Black), SifAcsm (Red), Cleavage Product 1 (Green), 
and Cleavage Product 2 (Blue). SifA, but not SifAcsm, displays a caspase-3 
concentration dependent decrease, which coincides with an increase in both 
Cleavage Product 1 and Cleavage Product 2.  
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SifA Colocalizes with Caspase-3 during infection 
To more deeply understand how the processing of SifA occurs through 
caspase-3 cleavage, we used the small fluorescent phiLOV tag to determine the 
extent to which we can observe caspase-3 and SifA colocalizing during an in 
vitro infection. This method does not interfere with secretion kinetics of the 
effector through the T3SS and can be used to examine de novo expression of 
T3SEs in vitro and in vivo [94, 96, 97]. As shown in Figure 2.3A, following 
infection of HeLa cells with Salmonella, SifA-phiLOV colocalizes with caspase-3 
beginning at 2 hpi (seen by yellow), with colocalization continuing through at 4 
hpi After 4 hr, colocalization was found to decrease (Figure 2.3A and 2.3B). Our 
prior studies found that increased caspase-3 activation occurs in SL1344-
infected intestinal epithelial cells over the first 5 hr of infection, with the effector 
protein SipA playing a central role [77]; thus such co-localization of SifA with 
caspase-3 is consistent with the timing of these events. Moreover, consistent 
with our previous findings [77], we show that early after Salmonella infection of 
epithelial cells this pathogen activates caspase-3, without inducing apoptosis as 
determined by a Western blot for activated caspase-3 (Figure 2.3C) and Annexin 
V staining (Figure 2.3D); as shown, infection with Salmonella expressing SifA-
phiLOV results in an increase in activated caspase-3 expression (via the function 
of SipA), but no significant difference in Annexin V positive cells in comparison to 
uninfected HeLa cells.  
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Figure 2.3. SifA colocalizes with caspase-3 during infection  
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Figure 2.3. SifA colocalizes with caspase-3 during infection.  A.) HeLa cells 
were infected with ∆ SifA/pSifA-phiLOV, fixed at 2, 4, and 8 hrs post-infection, 
stained with Image-iT LIVE Caspase-3 Detection Kit (ThermoFisher) and 
visualized using fluorescent confocal microscopy. Caspase-3 (Red) and SifA-
phiLOV (Green) can be seen colocalizing at 2 hrs post-infection (Yellow; bottom, 
left panel), with colocalization decreasing through 8 hrs. post-infection (bottom, 
bottom middle, and bottom right panels). B.) Colocalization of SifA-phiLOV and 
caspase-3 quantified using FIJI Software. C.) Western Blot for activated-
Caspase-3. HeLa cells were infected with indicated strains, lysed, and analyzed 
for activated caspase-3 expression. Protein concentration was determined using 
a Bradford Assay to ensure equal amounts of protein were loaded into each well 
D.) Annexin V Staining Assay. HeLa cells were infected with indicated strains, 
trypsinized, and stained with Annexin V. Flow cytometric analysis was then 
completed on a MACSQuant Analyzer to determine the number of Annexin 
positive cells. In comparison to the negative control (uninfected), HeLa cells only 
showed a significant increase in Annexin V positive cells with the use of 10µM of 
staurosporine. HeLa cells infected with WT-SL1344, ∆SifA, and ∆SifA/pSifA-
phiLOV all do not exhibit a significant change in Annexin V positive cells in 
comparison to negative control (uninfected). P Values (statistics calculated using 
unpaired Student’s t test): NS, not significant; *P < 0.05. Experiments were 
performed at least three times using cells of different passage. 
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Caspase-3 cleavage of SifA is necessary for dissemination 
SifA plays a key role in maintaining the integrity of the Salmonella-
containing vacuole (SCV) [89], through the formation of tubular membranous 
structures connected to SCVs named Salmonella-induced tubules. Because the 
formation of such tubules is an essential virulence requirement for intracellular 
replication in macrophages, and hence contributes to the ability of Salmonella to 
successfully disseminate to extraintestinal organs (i.e., liver and spleen), we next 
sought to determine whether caspase-3 cleavage of SifA is necessary for 
Salmonella dissemination. Using the murine model of Salmonella-induced 
enteritis, as described in the Methods, we found that consistent with prior reports 
[98], deletion of the sifA gene from S. Typhimurium results in a 1 log decrease in 
dissemination of bacteria to the liver (Figure 2.4A). 
Next, we complemented this SifA deletion strain of Salmonella with two 
plasmids; one expressing SifA and the other SifAcsm. We reasoned that if 
cleavage of SifA at the caspase-3 cleavage site was a critical event required for 
dissemination, we would expect to see the SifAcsm phenocopy the SifA deletion 
strain. As shown in Figure 2.4A, we found that when the caspase-3 cleavage site 
is mutated, we indeed observed a similar 1 log decrease in dissemination to the 
liver. However, when the SifA deletion strain is complemented with a plasmid 
containing SifA, there was a rescue of the phenotype to near wild-type levels of 
dissemination to the liver.  
While all strains colonized the large intestine to similar levels (Figure 
2.4B), we needed to rule out the possibility that the decrease in dissemination 
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observed for the SifAcsm mutant strain resulted from a defect in the ability to 
disseminate via the blood to the liver. We therefore delivered the Salmonella 
strains systemically through tail vein injection, and found that both the ∆SifA 
strain as well as the SifAcsm strain, showed similar levels of bacterial load in the 
liver as compared to the wild type and SifA-complemented strain (Figure 2.4C). 
Given that the SifAcsm strain does not demonstrate an impairment in either the 
ability to colonize the intestine or reach the liver when delivered systemically 
suggests that the defect observed results from a failure to disseminate from the 
intestine. 
 
 
Figure 2.4. Caspase-3 cleavage of SifA is necessary for 
dissemination  
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Figure 2.4. Caspase-3 cleavage of SifA is necessary for dissemination. A.) 
Mice were infected by oral gavage and livers were harvested 48 hrs. post-
infection. Bacterial burdens were determined by homogenizing the livers and 
serial dilution plating. ∆SifA and ∆SifA/pSifAcsm exhibit over 1 log decrease in 
bacterial burden in the liver. This decrease is restored upon complementation 
with pSifA. Results are averages of 6 mice per group +/- SD. B.) Mice were 
infected by oral gavage and proximal colon samples were taken 48 hr post-
infection. Bacterial burdens were determined similarly to (A). Results are 
averages of 6 mice per group +/- SD. ∆SifA, ∆SifA/pSifA, and ∆SifA/pSifAcsm do 
not exhibit any significant defects in colonization of the proximal colon in 
comparison to WT-SL1344. C.) Mice were infected via the tail vein, and livers 
were harvested 24 hr post-infection. Bacterial burden was determined similar to 
(A). In comparison to WT-SL1344, ∆SifA, ∆SifA/pSifA, and ∆SifA/pSifAcsm all 
show similar levels of bacteria in the liver. P Values (statistics calculated using 
unpaired Student’s t test): NS, not significant; *P < 0.05. Data shown are 
representative of at least three independent experiments.  
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Subcellular localization of SifA functional domains is dependent upon caspase-3 
cleavage 
Although we have been able to link SifA function to cleavage at the 
caspase-3 cleavage site, we next sought to determine whether the each of the 
SifA functional domains could be sub-cellularly tracked following caspase-3 
cleavage. SifA is ideal for addressing this question given that the N-terminal 
domain of SifA interacts with the pleckstrin homology domain of the host kinesin-
binding protein SKIP, and the C-terminal domain harbors a WxxxE motif that 
mimics the active the form of Rho-GTPases. If caspase-3 cleavage is necessary 
for SifA domain sub-cellular localization, then each of the functional domains 
would remain in the perinuclear region of the cell, where the SCV resides, until 
after its interaction with caspase-3. Then following caspase-3 cleavage, the 
individual functional domains would move to distinct subcellular locations to 
perform their functions. To this end, we designed dual-tagged V5-SifA-HA and 
dual-tagged V5-SifAcsm-HA (Figure 2.5A), allowing both red (V5) and green 
(HA) probes to be displayed on a single effector. In addition to the full-length 
protein, we also designed the individual domains (N and C terminal domain) with 
a single tag; V5-SifA (green) and SifA-HA (red).  
The benefit of using these constructs is that they permit us to directly 
investigate the involvement of the caspase-3 motif in SifA domain localization. 
The V5-SifA-HA and V5-SifAcsm-HA constructs can therefore be used to 
determine where each domain localizes during infection, and if the domain 
localization is dependent on caspase-3 cleavage. Additionally, the V5-SifA and 
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SifA-HA individual domain constructs can be used in combination with caspase-3 
KO HeLa cells to determine if we restore domain localization when we use 
individual domains that resemble their post-caspase-3 cleavage form. Two of 
these constructs (V5-SifA-HA and V5-SifAcsm-HA) were transduced into wild-
type Hela cells using lentiviral transduction. The plasmids used also had an 
inducible promoter, which allowed us to control expression of all four constructs.  
In order to stimulate caspase-3 activation typical of Salmonella infection, 
we infected the HeLa cells transduced with all four constructs with wild-type 
Salmonella, and then looked for the redistribution of each of the functional 
domains at 1 and 10 hpi using immunofluorescent confocal microscopy. 
Maximum Sif filament formation has been observed previously between 8 and 10 
hpi ([59, 99]; Supplementary Figure 2.1). Since we found that SifA colocalizes 
with caspase-3 at 2 hpi (Figure 2.2), we included this earlier point (1 hr) to 
determine the extent to which subcellular localizations change following the 
interaction of the SifA with caspase-3.  
At 1 hpi (prior to caspase-3 activation), we observe both SifA domains 
located in the perinuclear region for both V5-SifA-HA and V5-SifAcsm-HA (Figure 
2.5B, top left panel, Figure 2.5C). However, following interaction with caspase-3 
at 2 hpi, the N-terminal domain of V5-SifA-HA begins to branch out from the 
perinuclear region towards the extremities of the cell and continues to spread 
throughout the cell at 10 hpi. The role of caspase-3 processing in the domain 
localization of V5-SifA-HA domains is further supported by the profound 
decrease in colocalization of the SifA domains at 10 hpi (Figure 2.5B, 2.5C). 
	 67	
Additionally, we observed a significant increase in the relative distance of the N-
terminal domain from the nucleus for V5-SifA-HA at 10 hpi relative to 1 hpi 
(Figure 2.5D). We also observed this distance to be markedly larger when the 
caspase-3 site was intact, as evidenced by the significant difference at 10 hpi 
between V5-SifA-HA and V5-SifAcsm-HA (Figure 2.5D). This result is consistent 
with current literature indicating that the N-terminal domain of SifA binds to a 
protein called SKIP, and then forms Sif filaments via an interaction with kinesin 
[61]. Such Sif filaments are tubular membrane extensions that emanate from the 
SCV, which is located in the perinuclear region, towards the outer part of the cell. 
Considering the localization of the N-terminal domain for V5-SifA-HA, our results 
are in line with current understanding of SifA’s role in Sif filament formation. 
Since the C-terminal domain of SifA mimics host cell GTPases, and these 
host cell GTPases function in a variety of roles, including cellular division and 
actin cytoskeletal rearrangements, it is difficult to predict where the C-terminal 
domain of SifA would localize during Salmonella infection [100-102]. 
Furthermore, the C-terminal domain of SifA also contains a CaaX motif. The 
CaaX motif is prenylated by the geranylgeranyl transferase PGGT-1, which is a 
process that has been shown to facilitate attachment to cellular membranes 
[103]. On the balance of these reports, it would be feasible to observe the C-
terminal domain in the perinuclear region at the SCV membrane, the outer cell 
membrane, or both. However, as shown in Figure 2.5B and Figure 2.6A, the C 
terminal of SifA appears to remain primarily in the perinuclear region even after 
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interaction with caspase-3 at the 2 hr time point, indicating the C-terminal domain 
of SifA likely remains at the SCV membrane through the 10 hpi time point.  
We next determined the extent to which the caspase-3 site in SifA plays a 
role in the localization events we observed with V5-SifA-HA. To do this we used 
the V5-SifAcsm-HA construct and found that both of the functional domains of 
this strain remained in the perinuclear region for all time points following infection 
(Figure 2.5B). Additionally, we did not observe a similar decrease in V5-SifAcsm-
HA domain colocalization as observed with V5-SifA-HA (Figure 2.5C). This result 
suggests that processing of SifA at the caspase-3 site is essential for proper 
localization of each of the SifA domains, and further infers that the C-terminal 
domain appears to perform its “GTPase mimicry” function in the perinuclear 
region after it’s interaction with caspase-3. Nonetheless, further studies are 
required to discern whether the C-terminal domain of SifA is indeed functionally 
active at this location.  
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Figure 2.5. Subcellular localization of SifA functional domains is dependent 
upon caspase-3 cleavage 
	 70	
Figure 2.5. Subcellular localization of SifA functional domains is dependent 
upon caspase-3 cleavage. A.) Schematic depicting the dual-tagging strategy for 
SifA. The V5 tag (green) is used on the N-terminus and the HA tag (red) is used 
on the C-terminus. B.) Wild-type HeLa cells containing either V5-SifA-HA or V5-
SifAcsm-HA were infected with WT-SL1344. The cells were fixed and stained 
(refer to methods) at 1 and 10 hr post-infection. The N-terminus of SifA begins to 
branch out following interaction with caspase-3 at 2 hr post-infection (follow 
localization of green V5 tag from 1 – 10 hr post-infection), and the C-terminus of 
SifA remains in the perinuclear region for all time points following infection (red). 
When the caspase-3 cleavage site is mutated (V5-SifAcsm-HA), both domains 
(red and green) are observed in the perinuclear region at all time points following 
infection. Experiments were performed at least three times using cells of different 
passage. C.) Colocalization of the SifA N-terminal and C-terminal domains 
following caspase-3 cleavage quantified using FIJI Software. D.) Relative 
distance (measured using a micron scale) of the distance travelled by the N-
terminal domain in both V5-SifA-HA and V5-SifAcsm-HA at 1 and 10 hrs. post-
infection.  P Values (statistics calculated using unpaired Student’s t test): NS, not 
significant; **** P < 0.0001 
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Activated individual SifA domains restore SifA domain localization in Caspase-3 
KO Cells 
To further confirm the role of caspase-3 in the localization of the SifA 
functional domains, we generated caspase-3 KO HeLa cells using CRISPR/Cas9 
(refer to Methods). Additionally, we designed the V5-SifA and SifA-HA constructs 
containing individual domains (without the caspase-3 site) to assess whether we 
could restore localization each SifA functional domain by using a form of each 
domain that resembles their post-caspase-3 cleavage structure. V5-SifA-HA, V5-
SifA and SifA-HA were transduced into caspase-3 KO HeLa cells in the exact 
same manner as they were transduced into wild-type HeLa cells. As shown in 
Figure 2.6A, both domains of V5-SifA-HA remain in the perinuclear region in the 
caspase-3 KO cells for all time points following infection, phenocopying what we 
see in V5-SifAcsm-HA in wild-type HeLa cells. When we use the post-caspase-3 
cleavage form of each functional domain (V5-SifA and SifA-HA), we restore the 
domain localization we observed for V5-SifA-HA in wild-type HeLa cells, further 
implying that caspase-3 plays a pivotal role in the functional domain localization 
of SifA (Figure 2.6A). Although SifA-HA resembles the post-caspase-3 cleavage 
form of the SifA C-terminal domain, the relative distance from the nucleus does 
not change following infection as it does for V5-SifA (Figure 2.6B). These results 
agree with what is observed in Figure 5 for V5-SifA-HA in wild-type HeLa cells, 
indicating the perinuclear region of the HeLa cell is where the C-terminal domain 
of SifA is inferred to perform its function.   
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Figure 2.6. Activated individual SifA domains restore SifA domain 
localization in caspase-3 KO Cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 73	
 
Figure 2.6. Activated individual SifA domains restore SifA domain 
localization in caspase-3 KO Cells. Caspase-3 KO HeLa cells containing either 
V5-SifA-HA, V5-SifA or SifA-HA were infected with WT-SL1344. The cells were 
fixed and stained (refer to methods) at 1 and 8 hr post-infection. Without 
caspase-3, both domains of V5-SifA-HA remain in the perinuclear region at all 
time points following infection (top and bottom left panels), suggesting caspase-3 
cleavage is important for domain localization (compare to top panels in Fig. 5). 
When using V5-SifA, which resembles the post-caspase-3 cleavage form of the 
SifA N-terminal domain, we restore domain localization (top and bottom middle 
panels). Experiments were performed at least three times using cells of different 
passage. B.) Relative distance (measured using a micron scale) of the distance 
travelled by the N-terminal and C-terminal in both V5-SifA and SifA-HA at 1 and 8 
hrs. post-infection.  P Values (statistics calculated using unpaired Student’s t 
test): NS, not significant; **** P < 0.0001 
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Discussion 
In silico modeling of the SifA caspase-3 motif at the structural level 
revealed that this motif is surrounded by hydrophilic residues, exposed at the 
surface, and localized in coiled regions of proteins. This finding is consistent with 
two other crystallized structural homolog proteins of Salmonella effectors (SopA 
and SptP) that we examined (Supplementary Figure 2.2, and 2.3). This 
information coupled to the known structural data of SifA [61], suggested that 
cleavage of the caspase-3 motif in this effector divides this protein into an 
interacting partner for the host protein SKIP (N-terminal) and a member of the 
WxxxE family of proteins with GTPase mimicry function (C-terminal). We further 
report that cleavage of SifA by caspase-3 is indeed critical for proper localization 
of its functional domains, and is essential for bacterial dissemination from the 
intestine. Such data are consistent with prior evidence that each of these 
domains can function independently [61], and is also in step with recent findings 
that SifA can be split into two functional domains [91]. Our demonstration that 
caspase-3 cleavage of SifA is required for bacterial dissemination, adds to the 
emerging concept that caspase-3 sites are present and functionally active in 
T3SE. Such processing has been described for Salmonella invasion (SipA) [77], 
ubiquitination (SopA) [77], and now in this report for SCV maintenance and 
bacterial dissemination (SifA), implying that caspase-3 cleavage may have a 
broad impact on the bacteria’s ability to both invade and persist during infection.  
Although we have previously shown that the Salmonella T3SE, SipA, 
induces increased caspase-3 activity upon S. Typhimurium infection, such 
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activation remains insufficient to induce the signatures of apoptotic cell death 
([77], and this report). Thus, our data suggest that SipA is not only critical in 
inducing its own proteolytic cleavage but also that of other effectors such as SifA 
via its role in caspase-3 activation. This idea is consistent with our prior 
observations that Salmonella is significantly less virulent in caspase-3 knockout 
(CASP3-/-) mice and Salmonella invasiveness in bone-marrow-derived 
macrophages from CASP3-/- mice is profoundly reduced [77]. Moreover, in 
Salmonella strains lacking SipA, it has been previously described that SifA and 
SCVs are incorrectly positioned in the cell [1] and in a manner shown herein, 
since the function of SifA depends on activation by caspase-3.  
Method development for dual-tagging effectors permitted the tracking of 
effector proteins that also reflects the timeline of effector protein activation and 
localization during Salmonella infection. Unlike other strategies, this method does 
not rely on the T3SS secretion system for delivery of effector proteins, avoiding 
any complications associated with effector protein secretion kinetics or lack of 
secretion signals. The benefit to using this method is that it allows for the 
simultaneous tracking of domain localization and activation. One potential 
limitation to this method, however, is that it may be difficult to determine 
activation of T3SE domains if the localization does not change upon processing. 
For example, the subcellular localization of the N-terminal domain of SifA 
changes upon activation, whereas the C-terminal domain remains in the 
perinuclear region (Figure 2.5 and Figure 2.6). Although we speculate the C-
terminal domain is active, additional experimentation will be required to 
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determine if this is indeed the case. Nevertheless, dual-tagging of SifA 
demonstrated for the first time that the individual domains of SifA have different 
subcellular localizations. Additionally, the results from our dual tagging method, 
in conjunction with the findings of [1] suggest that the C-terminal domain alone 
may be acting to maintain the SCV in the perinuclear region, though further 
testing of this hypothesis is required to determine if this is indeed the case. 
Moreover, as Reinicke and colleagues demonstrated in [103], the process 
termed prenylation occurs at the CAAX motif in the C-terminal domain of SifA, 
which is a process important for membrane association. Taking into account the 
localization of the C-terminal domain determined in this study and the perinuclear 
localization of the SCV determined in [1], the prenylation of the C-terminal 
domain may be required for interaction with the SCV membrane in the 
perinuclear region, although further studies would be required to determine if this 
is true. 
Our prior studies revealed that S. Typhimurium T3SEs evolved the ability 
to use host enzymes, such as caspase-3 to activate themselves, displaying a 
high degree of co-evolution [77]. We speculate that the cleavage motifs of T3SEs 
have evolved over time and have targeted their cleavage and activation via 
different host enzymes depending on the host and cell type infected [104]. SipA, 
the first T3SE delivered into intestinal epithelial cells during infection is an 
excellent example of the evolution of a T3SE in response to selective pressures 
at the host-pathogen interface. With type III secretion requiring the delivery of a 
number of effectors rapidly over a short span of time, the formation of a chimeric 
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effector with a lone signal sequence and requiring just a single chaperone, 
greatly reduces the workload at the T3SS interface.  
The relationship between bacterial effectors and the activation of caspase-
3 is an area of increasing interest. While the outcome of such rearrangements 
results in independently functional domains coming together as one effector, this 
also creates a unique challenge in separation of the domains upon host cell 
delivery to ensure their correct location and function. It is now understood that 
caspase-3 is constantly present in the cell at levels below those required to 
induce apoptosis [94], suggesting that caspase-3 processing of effectors likely 
occurs throughout the cell rather than being dependent on contact merely at the 
cell surface or within the cytosol. Moreover, the interaction between effector 
proteins and caspase-3 may play a role in preventing caspase-3 from performing 
other important functions during infection, as has been described during Yersinia 
infection [105].  
 Caspase-3 activation during bacterial infection is also likely a common by-
product of the co-evolution of bacterial-host interactions, perhaps precipitated by 
the stress placed on host cells during invasion [106-109]. In addition to non-
specific or indirect activation of caspase-3, bacterial effectors are also able to 
promote caspase-3 activation through subtle changes within cellular pathways or 
even through direct interaction with the enzyme. The outcome for the pathogenic 
intruder, such as S. Typhimurium is often an increase in infectivity rather than a 
clearing of the infection as expected by the conventional understanding of the 
protective role of apoptosis.  
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The study herein therefore supports the concept that that caspase-3 
cleavage of T3SS secreted effectors represents a common mechanism by which 
effector functions are regulated in host cells. Understanding of this biological 
phenomenon as well as advancing methods to interrogate T3SE function inside 
host cells will allow us to dissect specific aspects of Salmonella-host interactions 
that have yet to be documented, and in general could have broad impact on the 
field of bacterial pathogenesis.  
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SUPPLEMENTARY FIGURES FOR CHAPTER II 
 
Supplementary Figure 2.1. Sif Filaments form between 8 and 10 hpi 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 2.1: Sif Filaments form between 8 and 10 hpi. Wild-
type HeLa cells were infected with WT-SL1344 or ∆SifA bacteria. Cells were 
fixed and stained using Anti-Salmonella LPS primary antibody (Abcam) and goat 
anti-rabbit 488 Alexa Fluor secondary antibody (Invitrogen) at 8 and 10 hpi. As 
shown in the top two panels, Sif filaments are visible at both 8 and 10 hpi (white 
arrows). Deletion of SifA, however, results in a loss of these Sif filaments. 
Experiments were performed at least three times using cells of different passage. 
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Supplementary Figure 2.2. The structural characteristics of the caspase-3 
motif in the Salmonella T3SE SopA 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 2.2. The structural characteristics of the caspase-3 
motif in Salmonella T3SE SopA. The structural features of the caspase-3 motif 
found in the Salmonella effector protein SopA (PDB ID 2QYU). Protein structures 
are displayed as cartoon (Panels a and b), surface (Panel c), and spheres 
(Panel c). Panel (a) shows protein structures colored with the spectrum color set 
of PyMOL to display the different protein domains, α-helixes, β-sheets, and coil 
regions. In Panels (b) and (c), the location of the caspase-3 motif is colored in 
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red, whereas in Panel (d) in yellow. In Panel (d), polar residues are colored in 
pink and hydrophobic in grey. DSFD and DCTD are putative caspase-3 motifs. 
PDB; Protein data bank. SopA: Confidence 98%; Identity 100%; Coverage 96%.  
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Supplementary	Figure	2.3.	The	structural	characteristics	of	the	caspase-3	
motif	in	Salmonella	T3SE	SptP 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary	Figure	2.3.	The	structural	characteristics	of	the	caspase-3	
motif	in	Salmonella	T3SE	SptP.	The	structural	features	of	the	caspase-3	motif	found	in	the	Salmonella	effector	protein	SptP	(PDB	ID	1G4W).	Protein	structures	are	displayed	as	cartoon	(Panels	a	and	b),	surface	(Panel	c),	and	spheres	(Panel	c).	
Panel	(a)	shows	protein	structures	colored	with	the	spectrum	color	set	of	PyMOL	to	display	the	different	protein	domains,	α-helixes,	β-sheets,	and	coil	regions.	In	
Panels	(b)	and	(c),	the	location	of	the	caspase-3	motif	is	colored	in	red,	whereas	in	
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Panel	(d)	in	yellow.	In	Panel	(d),	polar	residues	are	colored	in	pink	and	hydrophobic	in	grey.	DFRD	is	the	putative	caspase-3	motif.	PDB;	Protein	data	bank.	SifA:	Confidence	100%;	Identity	100%;	Coverage	44%.			
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APPENDIX A: Define the evolutionary relationship between 
caspase cleavage and their respective hosts by tracking effector 
evolution as an indicator of host adaptation 
 Although we found that caspase-3 processing of SifA, SipA, and SopA 
[77] is pivotal for the function of these effector proteins, we also found the 
presence of other proteolytic cleavage sites in effector proteins belonging to 
different serovars of Salmonella enterica. This finding could potentially be 
explained from an evolutionary perspective, in that different cleavage sites may 
have arose to increase the fitness of the bacteria depending on the particular 
host it was infecting.  
 In order to explore the possibility of proteolytic cleavage sites being 
related to host specificity and adaptation, we chose to examine the protein 
sequences of effector proteins across different serovars of Salmonella enterica. 
Preliminary data comparing SifA from Salmonella arizonae (S. arizonae) and S. 
Typhimurium revealed that the processing sites found in the SifA for these 
particular two serovars of Salmonella enterica were different. Absent from the 
SifA in S. arizonae is the caspase-3 cleavage site; however, there is a caspase-1 
cleavage site. This caspase-1 site is not found in SifA in S. Typhimurium (Figure 
A.1). So the obvious question arises: Why does the same effector protein have a 
different proteolytic cleavage site?  
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Figure A.1. Caspase processing sites in S. arizonae and S. Typhimurium 
 
 
 
 
 
 
 
 
 
 
Figure A.1. Caspase Processing Sites in S. arizonae and S. Typhimurium.  
By aligning the regions of SifA that contain caspase-3 cleavage sites in S. 
Typhimurium and comparing it to the same region of SifA from S. arizonae, we 
find that the caspase processing sites are different. The protein sequence for the 
proteolytic cleavage site of SifA in S. Typhimurium (highlighted in grey) is DRPD, 
a caspase-3 cleavage motif. The protein sequence for the proteolytic cleavage 
site of SifA in S. arizonae (highlighted in grey) is EQPV, a caspase-1 cleavage 
motif. This finding suggests that different serovars of Salmonella enterica could 
express different caspase processing sites, which we speculate may have 
evolved as a host adaptation mechanism. 
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In order to expand this inquiry further, we chose to compare the effector 
protein sequences of SPI-1 and SPI-2. After obtaining full genome sequences of 
various Salmonella enterica serovars that infected different hosts, we developed 
a phylogenetic tree to determine if we observed any differences that would show 
a correlation between proteolytic processing sites and host adaptation. The 
phylogenetic trees shown in Figure A.2A and Figure A.2B indicate that there is 
an evolutionary difference between the SPI-1 and SPI-2 protein sequences 
among different serovars of Salmonella enterica, which further substantiates our 
observation of the different cleavage sites in SifA of S. arizonae and S. 
Typhimurium. Although it does not entirely demonstrate that there are sequence 
differences in the individual effector proteins, it does demonstrate that there is an 
evolutionary difference in the protein sequences of SPI-1 and SPI-2 that relates 
to host specificity.  
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Figure A.2. Phylogenetic analysis of the SPI-1 and SPI-2 protein 
sequences of Salmonella enterica 
 
A. 
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B. 
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Figure A.2. Phylogenetic analysis of the SPI-1 and SPI-2 protein sequences 
of Salmonella enterica. Phylogenetic trees for both SPI-1 and SPI-2. A.) and B.) 
Phylogenetic tree of SPI-1 and SPI-2 protein sequences revealed that in 
relationship to S. Typhimurium, the SPI-1 and SPI-2 protein sequences of 
several other serovars of Salmonella enterica have evolutionary differences. This 
observation further supports the findings in A.1, namely that SifA in S. 
Typhimurium and SifA in S. arizone display different proteolytic cleavage sites. 
Labeling: The labels indicate the serovar of Salmonella enterica. Since the full 
genome sequences were obtained from infected patients, the numbers following 
some of the serovar names were used to identify the patient. The scale bar at the 
bottom of each phylogenetic tree indicates distance, which is used to measure 
the evolutionary similarity between the SPI-1 and SPI-2 protein sequences of 
each serovar in reference to S. Typhimurium. 
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As such, we chose to look at individual effector protein sequences from 
the different serovars of Salmonella enterica used to develop the phylogenetic 
tree. The results we obtained were surprisingly inconclusive, primarily due to the 
fact that we were unable to find any sequence differences in proteolytic cleavage 
sites among the effector proteins analyzed. This observation, however, does not 
exclude the possibility that a more comprehensive analysis that includes other 
species of Salmonella could yield results demonstrating differences in proteolytic 
cleavage sites. At this time, this type of broad analysis is rather challenging due 
to the fact that many full genomes and effector proteins do not have readily 
available full sequences that can be used for analysis. Thus, key questions 
regarding the correlation between proteolytic cleavage sites and host specificity 
remain, but it is important to acknowledge that the initial results from S. arizonae 
and S. Typhimurium suggest host adaptation might potentially play a role in the 
evolution of proteolytic cleavage sites in effector proteins.  
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CHAPTER III: Discussion 
Thesis Summary 
The findings described in this study address the question of whether or not 
caspase-3 processing of SifA is required for protein function and domain 
localization. The results from this work have expanded our knowledge of how S. 
Typhimurium utilizes host enzymes during an infection. Most importantly, this 
study allowed for the development of a potential model of effector protein 
activation -- proteolytic processing via the use of host enzymes is an activation 
paradigm used by S. Typhimurium to promote it’s own pathogenesis.  
 Previous observations from our lab demonstrated that caspase-3 cleavage 
of the T3SE SipA is required for activation of protein function and that both 
functional domains of SipA function independently [55, 76, 77]. Since SipA is 
involved in bacterial entry via its role in inducing inflammation and actin 
rearrangement, we sought out to determine whether effector proteins involved in 
intracellular survival and bacterial dissemination also required caspase-3 
processing for activation. As such, we chose to look at SifA, a SPI-2 effector 
protein containing a caspase-3 cleavage site that functions in inducing 
endosomal tubulation, which is required for SCV maintenance and bacterial 
dissemination.   
 We were able to demonstrate that SifA has a functionally active caspase-3 
cleavage site, and that caspase-3 cleavage was required for SifA function using 
previously established methods [Chapter 2]; however, in order to address the 
hypothesis that caspase-3 cleavage is important for subcellular localization of 
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SifA functional domains, we had to develop new methods to track effector 
proteins during Salmonella infection. As shown in Chapter 2, these new tracking 
methods were utilized to address three questions -- Do SifA and caspase-3 
colocalize during infection, is caspase-3 cleavage important for SifA functional 
domain localization, and is it possible to restore functional domain localization.  
Utilizing the phi-LOV tracking method, we were able to demonstrate that 
SifA and caspase-3 colocalize during infection. Moreover, we were able to use 
this method to demonstrate that this colocalization of SifA and caspase-3 occurs 
as early as 2 hrs. post-infection, and then decreases through 8 hrs. post-infection 
(Figure 2.3A and 2.3B). It is important to note that these results concur with the 
timeline of Sif filament formation, in that Sif filaments form between 8 hrs. and 10 
hrs. post-infection ([59, 99]; Supplementary Figure 2.1). If caspase-3 processing 
was required for Sif filament formation, then it would be expected for caspase-3 
and SifA to colocalize prior to their formation, which we were able to validate 
using the phi-LOV tracking method. 
Addressing the inquiry of SifA domain localization and restoration of 
domain localization required the development of a new effector protein tracking 
method. This method involved tagging SifA in a manner that would allow us to 
individually track each functional domain [Chapter 2; Figure 2.5 and 2.6]. The 
strategy we developed was dual-tagging SifA and SifAcsm, using a V5 tag on the 
N-terminal domain and a HA tag on the C-terminal domain (Figure 2.5A and 2.6). 
The premise behind this strategy was rooted in the idea that following infection 
we would be able to track each functional domain to their respective subcellular 
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locations. Additionally, our dual-tagging method would allow us to address the 
relevance of caspase-3 cleavage to SifA functional domain localization.  
As discussed in Chapter 2, we were able to demonstrate that caspase-3 
cleavage of SifA is required for proper subcellular localization of SifA functional 
domains utilizing our dual-tagging method (Figure 2.5 and 2.6). In further support 
of the significance of caspase-3 cleavage in SifA functional domain localization, 
we were able to show that individually tagged SifA domains that represented 
their post-cleavage activated forms restored subcellular localization (Figure 2.6). 
Thus, the use of our dual-tagging method allowed us to expand the role of 
caspase-3 processing from being pivotal in SifA function to also being essential 
for intracellular localization. 
 
Figure D.1. Summary of Findings 
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Figure D.1. Summary of Findings. A.) Prior to the work presented in this thesis, 
it was known that caspase-3 processing of SPI-1 effector proteins (i.e. SipA) was 
required for the induction of inflammation and actin binding. B.) Since SPI-1 
effector proteins are involved in bacterial entry, we sought to determine if SPI-2 
encoded effector proteins (involved in bacterial dissemination and SCV 
maintenance) also required caspase-3 processing for function and domain 
localization. We found that SifA not only requires caspase-3 cleavage for 
function, but that it is also required for proper domain localization. The N-terminal 
domain of SifA branches out from the SCV, which is consistent with the N-
terminal being involved in Sif filament formation. The C-terminal domain localizes 
to the perinuclear region, which could suggest that it is performing its GTPase 
mimcry function at the SCV membrane. Additional studies will be required to 
determine whether or not caspase-3 cleavage is important for individual domain 
function and interaction with host cell interacting partners C.) An interesting 
observation made was that the processing sites in different serovars of 
Salmonella appear to have different proteolytic cleavage sites. This suggests that 
Salmonela co-evolved with the hosts that they infect, as S. Typhimurium infects 
humans/poultry and S. arizonae infects alligators, though further studies are 
required to determine if this is indeed the case. Furthermore, it would be 
interesting to determine if the different “variants” of SifA play an identical role in 
the hosts that they infect. 
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Future Directions 
The role of caspase-3 in domain function 
Although we found that caspase-3 cleavage is required for bacterial 
dissemination and subcellular localization of SifA functional domains, there are 
still fundamental questions that remain. Perhaps the biggest question that 
remains is whether caspase-3 cleavage plays a role in the individual functions of 
each SifA domain. Specifically, is caspase-3 cleavage necessary for the N-
terminal domain of SifA to induce the formation of Sif filaments? Also, is 
caspase-3 cleavage necessary for the GTPase mimicry function of the C-terminal 
domain? Since caspase-3 cleavage of SifA is important for both bacterial 
dissemination and functional domain localization [Chapter 2], it is plausible that 
caspase-3 cleavage is also important for the functions of the individual domains 
of SifA. As the formation of Sif filaments via the function of the N-terminal domain 
is well documented, the involvement of caspase-3 processing in Sif filament 
formation could be addressed using the caspase-3 cleavage site mutant our lab 
has developed ([59-61, 99]; this study). However, the GTPase mimicry function 
of the C-terminal domain is not fully understood, and consequently it is difficult to 
develop an assay that would allow for a direct analysis of the involvement of 
caspase-3 processing in the function of this domain at this time. Nevertheless, it 
would be a worthwhile pursuit to determine the involvement of caspase-3 
processing in the functions of each SifA domain.  
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The role of caspase-3 processing in the interaction of individual domains with 
host cell interacting partners 
An additional question worth exploring is the possibility that proteolytic 
cleavage by caspase-3 is a prerequisite for interaction of SifA functional domains 
with their respective host cell interacting partners. Diacovich and colleagues 
demonstrated that the interaction between the N-terminal of SifA and its host cell 
interacting partner, SKIP, is essential for Salmonella pathogenesis [90]. Since 
both caspase-3 processing of SifA and SifA’s interaction with SKIP are vital for 
the virulence of Salmonella, it is tempting to speculate that caspase-3 processing 
could play a role in the ability of the N-terminal domain of SifA to interact with 
SKIP. Since antibodies for many effector proteins have yet to be developed, 
utilizing the dual-tagging method established in this study makes it possible to 
begin addressing this question. Unfortunately, a host cell interacting partner for 
the C-terminal domain has yet to be identified, though our data from Chapter 2 
(Figure 2.5 and 2.6) suggests the host cell interacting partner(s) of the C-terminal 
may be found in the perinuclear region and possibly at the SCV membrane. 
Nonetheless, if a C-terminal domain interacting partner is uncovered, the dual-
tagging method will be a useful tool in determining the relevance of caspase-3 
cleavage to the ability of both SifA functional domains to interact with their 
respective host cell interacting partners. 
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The role of caspase-3 processing in the functional interaction between effector 
proteins 
As discussed in the two previous paragraphs, it is possible for caspase-3 
cleavage to be required for both SifA individual domain function and also for the 
interaction of SifA domains with their respective host cell interacting partners. 
One intriguing question that remains is if the interaction between effector proteins 
also requires caspase-3 processing. Brawn and colleagues have demonstrated 
that SipA and SifA coordinate not only promote intracellular replication, but also 
to localize the SCV to the perinuclear region [1]. According to their model, 
deletion of SipA disrupts the localization of the SCV. Additionally, it is now known 
that both SipA and SifA require caspase-3 cleavage for function ([77] and this 
study). As such, it would be interesting to determine whether or not mutating the 
caspase-3 sites in either SipA or SifA affects the perinuclear localization of the 
SCV.  
Salmonella-induced activation of caspase-3 and apoptosis 
It is well documented that the terminal activation of caspase-3 results in 
apoptosis; however, in the case of Salmonella infection, we observe that 
apoptotic cell death does not occur until 18-20 hpi even though caspase-3 
activation is found to be increased during the first 5 hours following Salmonella 
infection [110]. This finding suggests that caspase-3 activation increases during 
the first 5 hpi because of the role caspase-3 plays in effector protein activation 
[77, 110]. In further support of this theory, Knodler and colleagues found that the 
effector protein SopB prevents apoptosis by sustained activation of Akt [110]. 
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Since SopB is one of the first effector proteins translocated into the host cell, it is 
plausible that SopB plays a pivotal role in the sustained activation of caspase-3 
without induction of apoptosis. It would be a worthwhile pursuit to determine if 
SopB requires caspase-3 processing for this function, as it does contain a 
caspase-3 cleavage site [77]. This could potentially demonstrate that not only 
does Salmonella activate caspase-3 for effector protein activation, but also has 
mechanisms based on effector protein function designed to regulate caspase-3 
activity. 
It still remains to be determined whether or not other effector proteins play 
a role in the prevention of apoptosis. Furthermore, considering that Rosado and 
colleagues demonstrated caspase-3 has roles in cellular functions not related to 
apoptosis, it would be intriguing to determine how Salmonella-induced activation 
of caspase-3 affects its involvement in other cellular functions [111].  
 
Evolution of proteolytic cleavage sites 
 It is still unclear as to why S. Typhimurium selected caspase-3 in order to 
process effector proteins. Indeed, the data in Appendix A does suggest there is 
an evolutionary relationship between effector proteins from different serovars of 
Salmonella, their processing sites, and the respective hosts that they infect. 
However, there are many other proteolytic enzymes that could have been 
evolutionarily selected in order to increase bacterial fitness in the same host. As 
such, looking further into the advantages or disadvantages of evolving particular 
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proteolytic processing sites in effector proteins could help further determine why 
individual serovars chose particular proteolytic enzymes.  
 In the case of S. Typhimurium, one possibility is that the additional roles 
caspase-3 plays in cellular function could be required or be a target for yet 
unidentified effector protein functions. Moreover, the manipulation of the 
additional roles caspase-3 plays in cellular function by effector proteins may 
potentially be required for Salmonella pathogenesis.   
 
Conclusion 
The findings reported in this study broaden our understanding of the role 
caspase-3 processing plays in the activation, function and localization of the S. 
Typhimurium effector protein SifA. They also demonstrate for the first time a 
direct correlation between the function and localization of a SPI-2 effector protein 
and proteolytic cleavage by caspase-3. Our results build upon previous 
observations made by our lab, namely that the SPI-1 effector proteins SipA and 
SopA require caspase-3 cleavage for function. Through the development of new 
tracking methodologies, we were able to further expand the role of caspase-3 
from being a critical for effector protein activation to also being critical for effector 
protein domain localization. Moreover, we demonstrate that the development of 
new methods to assess effector protein function will allow us to further advance 
our understanding of effector protein biology, ultimately leading to a more 
comprehensive understanding of the mechanisms used by S. Typhimurium to 
promote it’s own pathogenesis.  
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